US20030159185A1

US20030159185A1 - Replication protein A and use

Info

Publication number: US20030159185A1
Application number: US10/372,686
Authority: US
Inventors: Pramod Mahajan
Original assignee: Pioneer Hi Bred International Inc
Current assignee: Pioneer Hi Bred International Inc
Priority date: 1998-09-17
Filing date: 2003-02-21
Publication date: 2003-08-21
Also published as: US20040098769A1; IL142034A0; AU772568B2; US20030163840A1; WO2000015816A3; US6538176B1; EP1114170A2; WO2000015816A2; AU6042499A; JP2003510009A; AU772568C; WO2000015816A9; CA2337902A1

Abstract

Methods and compositions for modulating DNA metabolism are provided. Nucleotide and amino acid sequences encoding a maize replication protein A subunits are provided. The sequences can be used in expression cassettes for modulating DNA replication, DNA repair, and recombination.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a divisional of co-pending U.S. application Ser. No. 09/396,149 filed Dec. 15, 1999, and claims the benefit of U.S. Provisional Application Serial No. 60/100,690 filed Sep. 17, 1998, now abandoned and U.S. Provisional Application Serial No. 60/123,896 filed Mar. 11, 1999, now abandoned, which are all herein incorporated by reference.[0001]

FIELD OF THE INVENTION

The invention relates to the genetic manipulation of plants, particularly to modulating DNA metabolism in transformed plants and plant cells.

BACKGROUND OF THE INVENTION

Replication protein A (RPA) is a single-stranded DNA-binding protein that is required for multiple processes in eukaryotic cells. RPA from human cells is a stable complex of 70-, 32-, and 14-kDa subunits. Homologues of RPA have been identified in all eukaryotes examined. However, only human RPA and closely related homologues can support SV40 DNA replication.

The RPA complex appears to be highly conserved in all eukaryotes. The three RPA genes in budding yeast cells are essential for cell viability. Nevertheless, yeast RPA only partially substitutes for human RPA in the in vitro replication of simian virus 40 indicating that species-specific interactions between RPA and other replication proteins may be important for its biological activity.

RPA binds tightly to single stranded DNA as a heterotrimeric complex. The binding activity has been localized to the 70 kDa subunit. The affinity of RPA for both double-stranded DNA and RNA is at least three orders of magnitude lower than it is for single-stranded DNA. It has been reported that RPA binds preferentially to the pyrimidine-rich strand of both S. cerevisiae sequences and the SV40 origin of replication. However, studies examining the determinants of replication origins in S. cerevisiae indicate that this preferential binding is not critical for the initiation of DNA replication.

Subunits of RPA in the 70-, 32- and 14 kDa ranges have been identified from various sources. The 32 kDa subunit has also been referred to as “RPA2”, “B”, “small”, “32 kDa”, “P32”, “P34”, and “middle” subunit. For the purposes of this invention, the “middle” subunit is intended as the subunit having a molecular weight of about 32 kDa.

The middle subunit of RPA has a role in cell cycle regulation; single stranded DNA binding; affinity of DNA binding; species-specificity of DNA binding; DNA recombination, repair, replication and metabolism; and response to DNA damages. (Anderson (1966) Calif. Inst. Technol.; Seroussi et al. (1993) J. Biol. Chem. 268:7147-54; Kenny et al. (1989) Proc. Natl. Acad. Sci. USA 86:9757-61; Brush et al. (1995) Methods Enzymol. 262:522-48; Stigger et al. (1994) Proc. Natl. Acad. Sci. USA 91:579-83; Philipova et al. (1996) Genes Dev. 10:2222-33).

Much research has centered on the exploration of the biochemical and genetic mechanisms by which cell cycle regulation of DNA synthesis is achieved. While there have been advances in delineating the existence of cell cycle proteins, more information is needed on the mechanism of action of DNA replication, recombination, and repair. Furthermore, methods for regulating or altering the cell cycle is needed.

Related Literature

Braun et al. (1997) Biochemistry 36:8443-8454; report on the role of protein-protein interactions and the function of replication protein A. It is reported that RPA modulates the activity of DNA polymerase a by multiple mechanisms.

Loor et al. (1997) Nucleic Acids Research 25:5041-5046 report on the identification of DNA replication in cell cycle proteins that interact with proliferating cell nuclear antigen.

Longhese et al. (1994) Molecular and Cellular Biology 14:7884-7890 report that replication factor A is required for in vivo DNA replication, repair, and recombination.

Stigger et al. (1998) J. Biol. Chem. 273:9337-9343 provide a functional analysis of human replication protein A in nucleotide excision repair.

Abremova et al. (1997) Proc. Natl. Acad. Sci. USA 94:7186-7191 report that the interaction between replication protein A and p53 is disrupted after ultraviolet damage in a DNA repair-dependent manner.

New et al. (1998) Nature 391:407-410 reports that RAD52 protein stimulates DNA strand exchange by RAD51 and replication protein A. Stimulation was dependent on the concerted action of both RAD51 protein and RPA implying that specific protein-protein interactions between RAD52 protein, RAD51 protein and RPA are required.

Dutta et al. (1992) EMBO J. 11(6):2189-2199 and Niu et al. (1997) J. Biol. Chem.272(19):12634-41 report cell cycle-dependent phosphorylation of the middle subunit of RPA, implying a role for the subunit in cell cycle regulation.

Bochkareva et al. (1998) J. Biol. Chem. 273(7):3932-3936 report the formation of a single stranded DNA binding site on the human RPA middle subunit.

Mass et al. (1998) Mol. Cell. Biol. 18(11):6399-6407 report that the RPA middle subunit contacts nascent simian virus 40 DNA, particularly the early DNA chain intermediates synthesized by DNA polymerase alpha-primase (RNA-DNA primers), but not more advanced products.

Lavrik et al. (1998) Nucleic Acids Res 26(2):602-607 report on location of binding of individual subunits of human RPA to DNA primer-template complexes in various elongation reactions.

Sibenaller et al. (1998) 37(36):12496-12506 report that differences in the activity of the middle (32 kDa) and the small (14 Kda) subunits of RPA are responsible for variations in the single stranded DNA-binding properties of Saccharomyces cerevisiae and human RPA, thus implying a role for the subunits in species-specificity of DNA binding of RPA.

SUMMARY OF THE INVENTION

Compositions and methods for modulating DNA metabolism in a host cell is provided. Particularly, the complete cDNA and amino acid sequence for homologues of maize replication protein A (RPA) large- and middle subunits are provided. The sequences of the invention find use in modulating DNA replication, DNA repair, and recombination.

Transformed plants can be obtained having altered metabolic states. The invention has implications in genetic transformation and gene targeting in plants. Additionally, the methods can be used to promote cell death particularly in an inducible or tissue-preferred manner.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 provides a comparison of eukaryotic RPA large subunit amino acid sequences. Amino acid sequences for the RPA large subunits from [0023] Saccharomyces cerevisiae (Rfal Yeast, SEQ ID NO:10), Schizosaccharomyces pombe (Rfal_Schpo, SEQ ID NO: 9), Drosophila melanogaster (Rfal_Drome, SEQ ID NO:8), Homo sapiens (Rfal_Human, SEQ ID NO: 7), Xenopus laevis (Rfal_Xenla, SEQ ID NO: 6), and Oryza sativa (O24183, SEQ ID NO:5) were compared with the maize RPA LS homologue 1 (ZMRPALSH1, SEQ ID NO:2) and homologue 2 (ZMRPALSH2, SEQ ID NO:4) using the GCG PileUp program utilizing default parameters. The putative zinc finger region is shown in italics.
FIG. 2 provides an expression construct for inducible expression of the maize RPA large or middle subunit antisense construct.[0024]

DETAILED DESCRIPTION OF THE INVENTION

Nucleotide sequences and proteins useful for modulating DNA metabolism are provided. The nucleotide and amino acid sequences correspond to the maize replication protein A (RPA) subunits. RPA is a single-stranded DNA-binding protein that is required for multiple processes in DNA metabolism, including DNA replication, DNA repair, and recombination. The RPA complex generally comprises subunits of approximately 70, 32, and 14 kDa. By “large subunit”, “middle subunit”, and “small subunit” is herein intended a RPA subunit having the approximate molecular weight of 70-, 32-, and 14 kDa respectively. The sequences of the invention comprise the large- and middle subunits of the RPA complex. The sequences of the invention additionally find use in modulating gene expression. [0025]
Compositions of the invention include RPA nucleotide and amino acid sequences that are involved in modulating DNA metabolism. In particular, the present invention provides for isolated nucleic acid molecules comprising nucleotide sequences encoding the amino acid sequences shown in SEQ ID NOs: 2 and 4 for the large subunit, and SEQ ID NOs: 12, 14, 16, 18, 20, and 22 for the middle subunit. SEQ ID NO:2 and SEQ ID NO:4 correspond to the amino acid sequences for the maize RPA large subunit homologue 1 (ZmRPALSH1) and homologue 2 (ZmRPALSH2). SEQ ID NOs: 12, 14, 16, 18, 20, and 22 correspond to the amino acid sequences for the maize middle subunit homologue 1 (ZmRPAMSH1); [0026] homologues 2 and 3 (ZmRPAMSH2 and ZmRPAMSH3); homologue 4 (ZmRPAMSH4); homologue 5 (ZmRPAMSH5); homologue 6 (ZmRPAMSH6); and homologue 7 (ZmRPAMSH7) respectively.
For the large subunit, the present invention alternatively provides the nucleotide sequences encoding the DNA sequences deposited in a bacterial host as Patent Deposit Nos: 98754 and 98843. For the large subunits, further are polypeptides having an amino acid sequence encoded by a nucleic acid molecule described herein, for example those set forth in SEQ ID NOs: 1 and 3, those deposited in a bacterial host as Patent Deposit Nos: 98754 and 98843, and fragments and variants thereof. [0027]
Plasmids containing the RPA large subunit nucleotide sequences of the invention were deposited with the Patent Depository of the American Type Culture Collection (ATCC), Manassas, Va., and assigned Patent Deposit NOs: 98754 and 98843. These deposits will be maintained under the terms of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure. These deposits were made merely as a convenience for those of skill in the art and are not an admission that a deposit is required under 35 U.S.C. §112. [0028]
Nucleotide sequences encoding the amino acid sequences for the maize RPA large subunit homologue 1 (ZmRPALSH1) and homologue 2 (ZmRPALSH2) are set forth in [0029] SEQ ID NOs 1 and 3. Nucleotide sequences encoding the amino acid sequences for the maize RPA middle subunit homologue 1 (ZmRPAMSH1); homologues 2 and 3 (ZmRPAMSH2 and ZmRPAMSH3); homologue 4 (ZmRPAMSH4); homologue 5 (ZmRPAMSH5); homologue 6 (ZmRPAMSH6); and homologue 7 (ZmRPAMSH7) are set forth in SEQ ID NOs: 11, 13, 15, 17, 19, and 21 respectively.
The invention encompasses isolated or substantially purified nucleic acid or protein compositions. An “isolated” or “purified” nucleic acid molecule or protein, or biologically active portion thereof, is substantially free of other cellular material, or culture medium when produced by recombinant techniques, or substantially free of chemical precursors or other chemicals when chemically synthesized. Preferably, an “isolated” nucleic acid is free of sequences (preferably protein encoding sequences) that naturally flank the nucleic acid (i.e., sequences located at the 5′ and 3′ ends of the nucleic acid) in the genomic DNA of the organism from which the nucleic acid is derived. For example, in various embodiments, the isolated nucleic acid molecule can contain less than about 5 kb, 4 kb, 3 kb, 2 kb, 1 kb, 0.5 kb, or 0.1 kb of nucleotide sequences that naturally flank the nucleic acid molecule in genomic DNA of the cell from which the nucleic acid is derived. A protein that is substantially free of cellular material includes preparations of protein having less than about 30%, 20%, 10%, 5%, (by dry weight) of contaminating protein. When the protein of the invention or biologically active portion thereof is recombinantly produced, preferably culture medium represents less than about 30%, 20%, 10%, or 5% (by dry weight) of chemical precursors or non-protein-of-interest chemicals. [0030]
RPA binds tightly to single-stranded DNA (ssDNA). The affinity of binding to double-stranded DNA (dsDNA) is three to four orders of magnitude lower than the binding affinity for ssDNA. Because RPA has been found to bind specifically to certain dsDNA sequences that seem to be involved in the regulation of transcription, modulation of gene expression may be affected by an increase or decrease in RPA expression in the host cell. [0031]
RPA has a wide range of activity and therefore uses relating to DNA metabolism and cell cycle. RPA interacts specifically with several proteins required for nucleotide excision repair. Interactions with repair proteins indicate that RPA may be important for efficient damage recognition and cleavage. RPA additionally interacts with RAD52 protein, a protein that is essential for dsDNA-break repair. This interaction appears to be essential for homologous recombination. In this manner, expression of the nucleotides of the invention may promote homologous recombination by recruiting factors which are essential for recombination to occur. Thus, the methods and compositions of the invention find use in promoting homologous recombination. [0032]
In one embodiment, genetic manipulation by homologous recombination can be improved by either expression of the RPA coding sequences of the invention during transformation, or by providing RPA protein. RPA protein, for example, may be provided as a coating to particles during particle bombardment. Alternatively, DNA constructs providing for the expression of RPA may be included with the DNA to be transformed. The increase in RPA during transformation, particularly integration of polynucleotides by homologous recombination, promotes integration and insertion of the DNA sequences of interest into the plant genome. [0033]
In the same manner, it may be beneficial to inhibit the expression or presence of the RPA protein to encourage non-specific recombination events. In this manner, antibodies, peptides, antisense oligonucleotides and the like may be utilized to inhibit the activity of RPA. Alternatively, antisense constructs may be provided to inhibit the expression of RPA and encourage non-specific recombination. [0034]
Catalytic RNA molecules or ribozymes can also be used to inhibit expression of plant genes. It is possible to design ribozymes that specifically pair with virtually any target RNA and cleave the phosphodiester backbone at a specific location, thereby functionally inactivating the target RNA. In carrying out this cleavage, the ribozyme is not itself altered, and is thus capable of recycling and cleaving other molecules, making it a true enzyme. The inclusion of ribozyme sequences within antisense RNAs confers RNA-cleaving activity upon them, thereby increasing the activity of the constructs. The design and use of target RNA-specific ribozymes is described in Haseloff et al. (1988) [0035] Nature 334:585-591.
A variety of cross-linking agents, alkylating agents and radical generating species as pendant groups on polynucleotides of the present invention can be used to bind, label, detect, and/or cleave nucleic acids. For example, Vlassov, V. V. et al. (1986) [0036] Nucleic Acids Res. 14:4065-4076, describe covalent bonding of a single-stranded DNA fragment with alkylating derivatives of nucleotides complementary to target sequences. A report of similar work by the same group is that by Knorre et al. (1985) Biochimie 67:785-789. Iverson and Dervan also showed sequence-specific cleavage of single-stranded DNA mediated by incorporation of a modified nucleotide which was capable of activating cleavage (1987) J. Am. Chem. Soc. 109:1241-1243). Meyer et al. (1989) J. Am. Chem. Soc. 111:8517-8519, effect covalent crosslinking to a target nucleotide using an alkylating agent complementary to the single-stranded target nucleotide sequence. A photoactivated crosslinking to single-stranded oligonucleotides mediated by psoralen was disclosed by Lee et al. (1988) Biochem. 27:3197-3203. Use of crosslinking in triple-helix forming probes was also disclosed by Home et al. (1990) J. Am. Chem. Soc. 112:2435-2437. Use of N4, N4-ethanocytosine as an alkylating agent to crosslink to single-stranded oligonucleotides has also been described by Webb et al. (1986) J. Am. Chem. Soc. 108:2764-2765; Webb et al. (1986) Nucleic Acids Res. 14:7661-7674; Feteritz et al. (1991) J. Am. Chem. Soc. 113:4000. Various compounds to bind, detect, label, and/or cleave nucleic acids are known in the art. See, for example, U.S. Pat. Nos. 5,543,507; 5,672,593; 5,484,908; 5,256,648; and 5,681,941.
RPA is required for the replication of chromosomal DNA. Inhibition of endogenous RPA expression is deleterious to the cell, organism, or plant. Thus, the constructs of the invention can be used to selectively kill target cells or tissues. This can be accomplished through the use of inducible or tissue-preferred promoters. In this manner, the sequences of the invention may find use in enhancing pathogen resistance. An antisense construct for the RPA coding sequence is operably linked to a pathogen-inducible promoter. Upon contact with the pathogen, the RPA antisense construct is expressed resulting in cell death and effectively preventing the invasion of the pathogen. [0037]
The invention is drawn to compositions and methods for inducing resistance in a plant to plant pests. Accordingly, the compositions and methods are also useful in protecting plants against fungal pathogens, viruses, nematodes, insects and the like. [0038]
By “disease resistance” is intended that the plants avoid the disease symptoms that are the outcome of plant-pathogen interactions. That is, pathogens are prevented from causing plant diseases and the associated disease symptoms, or alternatively, the disease symptoms caused by the pathogen is minimized or lessened. The methods of the invention can be utilized to protect plants from disease, particularly those diseases that are caused by plant pathogens. [0039]
Pathogens of the invention include, but are not limited to, viruses or viroids, bacteria, insects, nematodes, fungi, and the like. Viruses include any plant virus, for example, tobacco or cucumber mosaic virus, ringspot virus, necrosis virus, maize dwarf mosaic virus, etc. Specific fungal and viral pathogens for the major crops include: Soybeans: [0040] Phytophthora megasperma fsp. glycinea, Macrophomina phaseolina, Rhizoctonia solani, Sclerotinia sclerotiorum, Fusarium oxysporum, Diaporthe phaseolorum var. sojae (Phomopsis sojae), Diaporthe phaseolorum var. caulivora, Sclerotium rolfsii, Cercospora kikuchii, Cercospora sojina, Peronospora manshurica, Colletotrichum dematium (Colletotichum truncatum), Corynespora cassiicola, Septoria glycines, Phyllosticta sojicola, Alternaria alternata, Pseudomonas syringae p.v. glycinea, Xanthomonas campestris p.v. phaseoli, Microsphaera diffusa, Fusarium semitectum, Phialophora gregata, Soybean mosaic virus, Glomerella glycines, Tobacco Ring spot virus, Tobacco Streak virus, Phakopsora pachyrhizi, Pythium aphamidermatum, Pythium ultimum, Pythium debaryanum, Tomato spotted wilt virus, Heterodera glycines Fusarium solani; Canola: Albugo candida, Alternaria brassicae, Leptosphaeria maculans, Rhizoctonia solani, Sclerotinia sclerotiorum, Mycosphaerella brassiccola, Pythium ultimum, Peronospora parasitica, Fusarium roseum, Alternaria alternata; Alfalfa: Clavibater michiganese subsp. insidiosum, Pythium ultimum, Pythium irregulare, Pythium splendens, Pythium debaryanum, Pythium aphamidermatum, Phytophthora megasperma, Peronospora trifoliorum, Phoma medicaginis var. medicaginis, Cercospora medicaginis, Pseudopeziza medicaginis, Leptotrochila medicaginis, Fusarium, Xanthomonas campestris p.v. alfalfae, Aphanomyces euteiches, Stemphylium herbarum, Stemphylium alfalfae; Wheat: Pseudomonas syringae p.v. atrofaciens, Urocystis agropyri, Xanthomonas campestris p.v. translucens, Pseudomonas syringae p.v. syringae, Alternaria alternata, Cladosporium herbarum, Fusarium graminearum, Fusarium avenaceum, Fusarium culmorum, Ustilago tritici, Ascochyta tritici, Cephalosporium gramineum, Collotetrichum graminicola, Erysiphe graminis f.sp. tritici, Puccinia graminis f.sp. tritici, Puccinia recondite f.sp. tritici, Puccinia striiformis, Pyrenophora tritici-repentis, Septoria nodorum, Septoria tritici, Septoria avenae, Pseudocercosporella herpotrichoides, Rhizoctonia solani, Rhizoctonia cerealis, Gaeumannomyces graminis var. tritici, Pythium aphamidermatum, Pythium arrhenomanes, Pythium ultimum, Bipolaris sorokiniana, Barley Yellow Dwarf Virus, Brome Mosaic Virus, Soil Borne Wheat Mosaic Virus, Wheat Streak Mosaic Virus, Wheat Spindle Streak Virus, American Wheat Striate Virus, Claviceps purpurea, Tilletia tritici, Tilletia laevis, Ustilago tritici, Tilletia indica, Rhizoctonia solani, Pythium arrhenomannes, Pythium gramicola, Pythium aphamidermatum, High Plains Virus, European wheat striate virus; Sunflower: Plasmophora halstedii, Sclerotinia sclerotiorum, Aster Yellows, Septoria helianthi, Phomopsis helianthi, Alternaria helianthi, Alternaria zinniae, Botrytis cinerea, Phoma macdonaldii, Macrophomina phaseolina, Erysiphe cichoracearum, Rhizopus oryzae, Rhizopus arrhizus, Rhizopus stolonifer, Puccinia helianthi, Verticillium dahliae, Erwinia carotovorum pv. carotovora, Cephalosporium acremonium, Phytophthora cryptogea, Albugo tragopogonis; Corn: Fusarium moniliforme var. subglutinans, Erwinia stewartii, Fusarium moniliforme, Gibberella zeae (Fusarium graminearum), Stenocarpella maydi (Diplodia maydis), Pythium irregulare, Pythium debaryanum, Pythium graminicola, Pythium splendens, Pythium ultimum, Pythium aphamidermatum, Aspergillus flavus, Bipolaris maydis O, T (Cochliobolus heterostrophus), Helminthosporium carbonum I, II & III (Cochliobolus carbonum), Exserohilum turcicum I, II & III, Helminthosporium pedicellatum, Physoderma maydis, Phyllosticta maydis, Kabatiella maydis, Cercospora sorghi, Ustilago maydis, Puccinia sorghi, Puccinia polysora, Macrophomina phaseolina, Penicillium oxalicum, Nigrospora oryzae, Cladosporium herbarum, Curvularia lunata, Curvularia inaequalis, Curvularia pallescens, Clavibacter michiganense subsp. nebraskense, Trichoderma viride, Maize Dwarf Mosaic Virus A & B, Wheat Streak Mosaic Virus, Maize Chlorotic Dwarf Virus, Claviceps sorghi, Pseudonomas avenae, Erwinia chrysanthemi pv. zea, Erwinia carotovora, Corn stunt spiroplasma, Diplodia macrospora, Sclerophthora macrospora, Peronosclerospora sorghi, Peronosclerospora philippinensis, Peronosclerospora maydis, Peronosclerospora sacchari, Sphacelotheca reiliana, Physopella zeae, Cephalosporium maydis, Cephalosporium acremonium, Maize Chlorotic Mottle Virus, High Plains Virus, Maize Mosaic Virus, Maize Rayado Fino Virus, Maize Streak Virus, Maize Stripe Virus, Maize Rough Dwarf Virus; Sorghum: Exserohilum turcicum, Colletotrichum graminicola (Glomerella graminicola), Cercospora sorghi, Gloeocercospora sorghi, Ascochyta sorghina, Pseudomonas syringae p.v. syringae, Xanthomonas campestris p.v. holcicola, Pseudomonas andropogonis, Puccinia purpurea, Macrophomina phaseolina, Perconia circinata, Fusarium moniliforme, Alternaria alternata, Bipolaris sorghicola, Helminthosporium sorghicola, Curvularia lunata, Phoma insidiosa, Pseudomonas avenae (Pseudomonas alboprecipitans), Ramulispora sorghi, Ramulispora sorghicola, Phyllachara sacchari, Sporisorium reilianum (Sphacelotheca reiliana), Sphacelotheca cruenta, Sporisorium sorghi, Sugarcane mosaic H, Maize Dwarf Mosaic Virus A & B, Claviceps sorghi, Rhizoctonia solani, Acremonium strictum, Sclerophthona macrospora, Peronosclerospora sorghi, Peronosclerospora philippinensis, Sclerospora graminicola, Fusarium graminearum, Fusarium oxysporum, Pythium arrhenomanes, Pythium graminicola, etc.
Nematodes include parasitic nematodes such as root-knot, cyst, and lesion nematodes, including Heterodera and Globodera spp; particularly [0041] Globodera rostochiensis and globodera pailida (potato cyst nematodes); Heterodera glycines (soybean cyst nematode); Heterodera schachtii (beet cyst nematode); and Heterodera avenae (cereal cyst nematode).
Insect pests include insects selected from the orders Coleoptera, Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera, Orthoptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera, Trichoptera, etc., particularly Coleoptera and Lepidoptera. Insect pests of the invention for the major crops include: Maize: [0042] Ostrinia nubilalis, European corn borer; Agrotis ipsilon, black cutworm; Helicoverpa zea, corn earworm; Spodoptera frugiperda, fall armyworm; Diatraea grandiosella, southwestern corn borer; Elasmopalpus lignosellus, lesser cornstalk borer; Diatraea saccharalis, surgarcane borer; Diabrotica virgifera, western corn rootworm; Diabrotica longicornis barberi, northern corn rootworm; Diabrotica undecimpunctata howardi, southern corn rootworm; Melanotus spp., wireworms; Cyclocephala borealis, northern masked chafer (white grub); Cyclocephala immaculata, southern masked chafer (white grub); Popillia japonica, Japanese beetle; Chaetocnema pulicaria, corn flea beetle; Sphenophorus maidis, maize billbug; Rhopalosiphum maidis, corn leaf aphid; Anuraphis maidiradicis, corn root aphid; Blissus leucopterus leucopterus, chinch bug; Melanoplus femurrubrum, redlegged grasshopper; Melanoplus sanguinipes, migratory grasshopper; Hylemya platura, seedcorn maggot; Agromyza parvicornis, corn blot leafminer; Anaphothrips obscrurus, grass thrips; Solenopsis milesta, thief ant; Tetranychus urticae, twospotted spider mite; Sorghum: Chilo partellus, sorghum borer; Spodoptera frugiperda, fall armyworm; Helicoverpa zea, corn earworm; Elasmopalpus lignosellus, lesser cornstalk borer; Feltia subterranea, granulate cutworm; Phyllophaga crinita, white grub; Eleodes, Conoderus, and Aeolus spp., wireworms; Oulema melanopus, cereal leaf beetle; Chaetocnema pulicaria, corn flea beetle; Sphenophorus maidis, maize billbug; Rhopalosiphum maidis; corn leaf aphid; Sipha flava, yellow sugarcane aphid; Blissus leucopterus leucopterus, chinch bug; Contarinia sorghicola, sorghum midge; Tetranychus cinnabarinus, carmine spider mite; Tetranychus urticae, twospotted spider mite; Wheat: Pseudaletia unipunctata, army worm; Spodoptera frugiperda, fall armyworm; Elasmopalpus lignosellus, lesser cornstalk borer; Agrotis orthogonia, western cutworm; Elasmopalpus lignosellus, lesser cornstalk borer; Oulema melanopus, cereal leaf beetle; Hypera punctata, clover leaf weevil; Diabrotica undecimpunctata howardi, southern corn rootworm; Russian wheat aphid; Schizaphis graminum, greenbug; Macrosiphum avenae, English grain aphid; Melanoplus femurrubrum, redlegged grasshopper; Melanoplus differentialis, differential grasshopper; Melanoplus sanguinipes, migratory grasshopper; Mayetiola destructor, Hessian fly; Sitodiplosis mosellana, wheat midge; Meromyza americana, wheat stem maggot; Hylemya coarctata, wheat bulb fly; Frankliniella fusca, tobacco thrips; Cephus cinctus, wheat stem sawfly; Aceria tulipae, wheat curl mite; Sunflower: Suleima helianthana, sunflower bud moth; Homoeosoma electellum, sunflower moth; zygogramma exclamationis, sunflower beetle; Bothyrus gibbosus, carrot beetle; Neolasioptera murtfeldtiana, sunflower seed midge; Cotton: Heliothis virescens, cotton budworm; Helicoverpa zea, cotton bollworm; Spodoptera exigua, beet armyworm; Pectinophora gossypiella, pink bollworm; Anthonomus grandis grandis, boll weevil; Aphis gossypii, cotton aphid; Pseudatomoscelis seriatus, cotton fleahopper; Trialeurodes abutilonea, bandedwinged whitefly; Lygus lineolaris, tarnished plant bug; Melanoplus femurrubrum, redlegged grasshopper; Melanoplus differentialis, differential grasshopper; Thrips tabaci, onion thrips; Franklinkiella fusca, tobacco thrips; Tetranychus cinnabarinus, carmine spider mite; Tetranychus urticae, twospotted spider mite; Rice: Diatraea saccharalis, sugarcane borer; Spodoptera frugiperda, fall armyworm; Helicoverpa zea, corn earworm; Colaspis brunnea, grape colaspis; Lissorhoptrus oryzophilus, rice water weevil; Sitophilus oryzae, rice weevil; Nephotettix nigropictus, rice leafhopper; Blissus leucopterus leucopterus, chinch bug; Acrosternum hilare, green stink bug; Soybean: Pseudoplusia includens, soybean looper; Anticarsia gemmatalis, velvetbean caterpillar; Plathypena scabra, green cloverworm; Ostrinia nubilalis, European corn borer; Agrotis ipsilon, black cutworm; Spodoptera exigua, beet armyworm; Heliothis virescens, cotton budworm; Helicoverpa zea, cotton bollworm; Epilachna varivestis, Mexican bean beetle; Myzus persicae, green peach aphid; Empoasca fabae, potato leafhopper; Acrosternum hilare, green stink bug; Melanoplus femurrubrum, redlegged grasshopper; Melanoplus differentialis, differential grasshopper; Hylemya platura, seedcorn maggot; Sericothrips variabilis, soybean thrips; Thrips tabaci, onion thrips; Tetranychus turkestani, strawberry spider mite; Tetranychus urticae, twospotted spider mite; Barley: Ostrinia nubilalis, European corn borer; Agrotis ipsilon, black cutworm; Schizaphis graminum, greenbug; Blissus leucopterus leucopterus, chinch bug; Acrosternum hilare, green stink bug; Euschistus servus, brown stink bug; Delia platura, seedcorn maggot; Mayetiola destructor, Hessian fly; Petrobia latens, brown wheat mite; Oil Seed Rape: Brevicoryne brassicae, cabbage aphid; Phyllotreta cruciferae, Flea beetle; Mamestra configurata, Bertha armyworm; Plutella xylostella, Diamond-back moth; Delia ssp., Root maggots.
A number of promoters can be used in the practice of the invention. The promoters can be selected based on the desired outcome. The nucleic acids can be combined with constitutive, tissue-preferred, or other promoters for expression in plants. [0043]
A plant promoter can be employed which will direct expression of a polynucleotide of the present invention in all tissues of a regenerated plant. Such promoters are referred to herein as “constitutive” promoters and are active under most environmental conditions and states of development or cell differentiation. Such constitutive promoters include, for example, the core promoter of the Rsyn7 (WO 99/43838); the core CaMV 35S promoter (Odell et al. (1985) [0044] Nature 313:810-812); rice actin (McElroy et a. (1990) Plant Cell 2:163-171); ubiquitin (Christensen et al. (1989) Plant Mol. Biol. 12:619-632 and Christensen et al. (1992) Plant Mol. Biol. 18:675-689); pEMU (Last et a. (1991) Theor. Appl. Genet. 81:581-588); MAS (Velten et al. (1984) EMBO J. 3:2723-2730); ALS promoter (U.S. Pat. No. 5,659,026), and the like. Other constitutive promoters include, for example, U.S. Pat. Nos. 5,608,149; 5,608,144; 5,604,121; 5,569,597; 5,466,785; 5,399,680; 5,268,463; and 5,608,142.
Alternatively, the plant promoter can direct expression of a polynucleotide of present invention in a specific tissue or may be otherwise under more precise environmental or developmental control. Such promoters are referred to here as “inducible” promoters. Environmental conditions that may effect transcription by inducible promoters include pathogen attack, anaerobic conditions, or the presence of light. Examples of inducible promoters are the Adhl promoter which is inducible by hypoxia or cold stress, the Hsp70 promoter which is inducible by heat stress, and the PPDK promoter which is inducible by light. [0045]
Examples of promoters under developmental control include promoters that initiate transcription only, or preferentially, in certain tissues, such as leaves, roots, fruit, seeds, or flowers. An exemplary promoter is the anther specific promoter 5126 (U.S. Pat. Nos. 5,689,049 and 5,689,051). The operation of a promoter may also vary depending on its location in the genome. Thus, an inducible promoter may become fully or partially constitutive in certain locations. [0046]
The promoters can be selected based on the desired outcome. When the genes are expressed at levels to cause cell death, an inducible promoter or tissue specific promoters can be used to drive the expression of the genes of the invention. The inducible promoter must be tightly regulated to prevent unnecessary cell death, yet be expressed in the presence of a pathogen to prevent infection and disease symptoms. [0047]
Generally, it will be beneficial to express the gene from an inducible promoter, particularly from a pathogen-inducible promoter. Such promoters include those from pathogenesis-related proteins (PR proteins), which are induced following infection by a pathogen; e.g., PR proteins, SAR proteins, beta-1,3-glucanase, chitinase, etc. See, for example, Redolfi et al. (1983) [0048] Neth. J. Plant Pathol. 89:245-254; Uknes et al. (1992) Plant Cell 4:645-656; and Van Loon (1985) Plant Mol. Virol. 4:111-116. See also U.S. Pat. No. 6,429,362, herein incorporated by reference.
Of interest are promoters that are expressed locally at or near the site of pathogen infection. See, for example, Marineau et al. (1987) [0049] Plant Mol. Biol. 9:335-342; Matton et al. (1989) Molecular Plant-Microbe Interactions 2:325-331; Somsisch et al. (1986) Proc. Natl. Acad. Sci. USA 83:2427-2430; Somsisch et al. (1988) Mol. Gen. Genet. 2:93-98; and Yang (1996) Proc. Natl. Acad. Sci. USA 93:14972-14977. See also, Chen et al (1996) Plant J. 10:955-966; Zhang et al. (1994) Proc. Natl. Acad. Sci. USA 91:2507-2511; Warner et al. (1993) Plant J. 3:191-201; Siebertz et al. (1989) Plant Cell 1:961-968; U.S. Pat. No. 5,750,386 (nematode-inducible); and the references cited therein. Of particular interest is the inducible promoter for the maize PRms gene, whose expression is induced by the pathogen Fusarium moniliforme (see, for example, Cordero et al. (1992) Physiol. Mol. Plant Path. 41:189-200).
Additionally, as pathogens find entry into plants through wounds or insect damage, a wound-inducible promoter may be used in the constructions of the invention. Such wound-inducible promoters include potato proteinase inhibitor (pin II) gene (Ryan (1990) [0050] Ann. Rev. Phytopath. 28:425-449; Duan et al. (1996) Nature Biotechnology 14:494498); wun1 and wun2, U.S. Pat. No. 5,428,148; win1 and win2 (Stanford et al. (1989) Mol. Gen. Genet. 215:200-208); systemin (McGurl et al. (1992) Science 225:1570-1573); WIP1 (Rohmeier et al. (1993) Plant Mol. Biol. 22:783-792; Eckelkamp et al. (1993) FEBS Letters 323:73-76); MPI gene (Corderok et al. (1994) Plant J. 6(2):141-150); and the like, herein incorporated by reference.
Chemical-regulated promoters can be used to modulate the expression of a gene in a plant through the application of an exogenous chemical regulator. Depending upon the objective, the promoter may be a chemical-inducible promoter, where application of the chemical induces gene expression, or a chemical-repressible promoter, where application of the chemical represses gene expression. Chemical-inducible promoters are known in the art and include, but are not limited to, the maize In2-2 promoter, which is activated by benzenesulfonamide herbicide safeners, the maize GST promoter, which is activated by hydrophobic electrophilic compounds that are used as pre-emergent herbicides, and the tobacco PR-la promoter, which is activated by salicylic acid. Other chemical-regulated promoters of interest include steroid-responsive promoters (see, for example, the glucocorticoid-inducible promoter in Schena et al. (1991) [0051] Proc. Natl. Acad. Sci. USA 88:10421-10425 and McNellis et al. (1998) Plant J. 14(2):247-257) and tetracycline-inducible and tetracycline-repressible promoters (see, for example, Gatz et al. (1991) Mol. Gen. Genet 227:229-237, and U.S. Pat. Nos. 5,814,618 and 5,789,156), herein incorporated by reference.
Where low level expression is desired, weak promoters will be used. Generally, by “weak promoter” is intended a promoter that drives expression of a coding sequence at a low level. By low level is intended at levels of about {fraction (1/1000)} transcripts to about {fraction (1/100,000)} transcripts to about {fraction (1/500,000)} transcripts. Alternatively, it is recognized that weak promoters also encompasses promoters that are expressed in only a few cells and not in others to give a total low level of expression. Where a promoter is expressed at unacceptably high levels, portions of the promoter sequence can be deleted or modified to decrease expression levels. [0052]
Such weak constitutive promoters include, for example, the core promoter of the Rsyn7 (WO 99/43838), the core 35S CaMV promoter, and the like. Other constitutive promoters include, for example, U.S. Pat. Nos. 5,608,149; 5,608,144; 5,604,121; 5,569,597; 5,466,785; 5,399,680; 5,268,463; and 5,608,142. See also, U.S. Pat. No. 6,177,611, herein incorporated by reference. [0053]
Tissue-preferred promoters can be utilized to target enhanced RPA expression within a particular plant tissue. In this aspect of the invention, the antisense constructs are useful for tissue-preferred expression. Male or female sterility may be affected by use of the antisense constructs with tissue-preferred promoters. Although not a limitation, of particular interest are promoters for male sterility. For example, the anther-preferred promoter 5126 can be used. See, for example, U.S. Pat. Nos. 5,689,049 and 5,689,051, herein incorporated by reference. [0054]
Tissue-preferred promoters include Yamamoto et al. (1997) [0055] Plant J. 12(2)255-265; Kawamata et al. (1997) Plant Cell Physiol. 38(7):792-803; Hansen et al. (1997) Mol. Gen Genet 254(3):337-343; Russell et al. (1997) Transgenic Res. 6(2):157-168; Rinehart et al. (1996) Plant Physiol. 112(3): 1331-1341; Van Camp et al. (1996) Plant Physiol. 112(2):525-535; Canevascini et al. (1996) Plant Physiol. 112(2):513-524; Yamamoto et al. (1994) Plant Cell Physiol. 35(5):773-778; Lam (1994) Results Probl. Cell Differ. 20:181-196; Orozco et al. (1993) Plant Mol Biol. 23(6):1129-1138; Matsuoka et al. (1993) Proc Natl. Acad. Sci. USA 90(20):9586-9590; and Guevara-Garcia et al. (1993) Plant J. 4(3):495-505. Such promoters can be modified, if necessary, for weak expression.
Leaf-specific promoters are known in the art. See, for example, Yamamoto et al. (1997) [0056] Plant J. 12(2):255-265; Kwon et al. (1994) Plant Physiol. 105:357-67; Yamamoto et al. (1994) Plant Cell Physiol. 35(5):773-778; Gotor et al. (1993) Plant J. 3:509-18; Orozco et al. (1993) Plant Mol. Biol. 23(6):1129-1138; and Matsuoka et al. (1993) Proc. Natl. Acad. Sci. USA 90(20):9586-9590.
Root-specific promoters are known and can be selected from the many available from the literature or isolated de novo from various compatible species. See, for example, Hire et al. (1992) [0057] Plant Mol. Biol. 20(2): 207-218 (soybean root-specific glutamine synthetase gene); Keller and Baumgartner (1991) Plant Cell 3(10):1051-1061 (root-specific control element in the GRP 1.8 gene of French bean); Sanger et al. (1990) Plant Mol. Biol. 14(3):433-443 (root-specific promoter of the mannopine synthase (MAS) gene of Agrobacterium tumefaciens); and Miao et al. (1991) Plant Cell 3(1):11-22 (full-length cDNA clone encoding cytosolic glutamine synthetase (GS), which is expressed in roots and root nodules of soybean). See also Bogusz et al. (1990) Plant Cell 2(7):633-641, where two root-specific promoters isolated from hemoglobin genes from the nitrogen-fixing nonlegume Parasponia andersonii and the related non-nitrogen-fixing nonlegume Trema tomentosa are described. The promoters of these genes were linked to a β-glucuronidase reporter gene and introduced into both the nonlegume Nicotiana tabacum and the legume Lotus corniculatus, and in both instances root-specific promoter activity was preserved. Leach and Aoyagi (1991) describe their analysis of the promoters of the highly expressed rolC and rolD root-inducing genes of Agrobacterium rhizogenes (see Plant Science (Limerick) 79(1):69-76). They concluded that enhancer and tissue-preferred DNA determinants are dissociated in those promoters. Teeri et al. (1989) used gene fusion to lacZ to show that the Agrobacterium T-DNA gene encoding octopine synthase is especially active in the epidermis of the root tip and that the TR2′ gene is root specific in the intact plant and stimulated by wounding in leaf tissue, an especially desirable combination of characteristics for use with an insecticidal or larvicidal gene (see EMBO J. 8(2):343-350). The TR1′ gene, fused to nptII (neomycin phosphotransferase II) showed similar characteristics. Additional root-preferred promoters include the VfENOD-GRP3 gene promoter (Kuster et al. (1995) Plant Mol. Biol. 29(4):759-772); and rolB promoter (Capana et al. (1994) Plant Mol. Biol. 25(4):681-691. See also U.S. Pat. Nos. 5,837,876; 5,750,386; 5,633,363; 5,459,252; 5,401,836; 5,110,732; and 5,023,179.
“Seed-preferred” promoters include both “seed-specific” promoters (those promoters active during seed development such as promoters of seed storage proteins) as well as “seed-germinating” promoters (those promoters active during seed germination). See Thompson et al. (1989) [0058] BioEssays 10:108, herein incorporated by reference. Such seed-preferred promoters include, but are not limited to, Cim1 (cytokinin-induced message); cZ19B1 (maize 19 kDa zein); milps (myo-inositol-1-phosphate synthase); and celA (cellulose synthase) (see U.S. Pat. No. 6,225,529, herein incorporated by reference). Gamma-zein is a preferred endosperm-specific promoter. Glob-1 is a preferred embryo-specific promoter. For dicots, seed-specific promoters include, but are not limited to, bean β-phaseolin, napin, β-conglycinin, soybean lectin, cruciferin, and the like. For monocots, seed-specific promoters include, but are not limited to, maize 15 kDa zein, 22 kDa zein, 27 kDa zein, g-zein, waxy, shrunken 1, shrunken 2, globulin 1, etc.
Both heterologous and non-heterologous (i.e., endogenous) promoters can be employed to direct expression of the nucleic acids of the present invention. These promoters can also be used, for example, in recombinant expression cassettes to drive expression of antisense nucleic acids to reduce, increase, or alter RPA content and/or composition in a desired tissue, or to generate sterile plants. Optionally, RPA nucleic acids from a variety of sources, as discussed above can be employed to create male sterile plants. In optional embodiments, the RPA gene or cDNA is operably linked to an anther-specific promoter such as 5126, as discussed above. Preferably, the male sterile plant is maize. [0059]
Thus, in some embodiments, the nucleic acid construct will comprise a promoter functional in a plant cell, such as in [0060] Zea mays, operably linked to a polynucleotide of the present invention. Promoters useful in these embodiments include the endogenous promoters driving expression of a polypeptide of the present invention.
In some embodiments, isolated nucleic acids which serve as promoter or enhancer elements can be introduced in the appropriate position (generally upstream) of a non-heterologous form of a polynucleotide of the present invention so as to up or down regulate expression of a polynucleotide of the present invention. For example, endogenous promoters can be altered in vivo by mutation, deletion, and/or substitution (see, Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868), or isolated promoters can be introduced into a plant cell in the proper orientation and distance from a RPA gene so as to control the expression of the gene. Gene expression can be modulated under conditions suitable for plant growth so as to alter RPA content and/or composition. Thus, the present invention provides compositions, and methods for making, heterologous promoters and/or enhancers operably linked to a native, endogenous (i.e., non-heterologous) form of a polynucleotide of the present invention. [0061]
Methods for identifying promoters with a particular expression pattern, in terms of e.g., tissue type, cell type, stage of development, and/or environmental conditions, are well known in the art. See, e.g., [0062] The Maize Handbook, Chapters 114-115, Freeling and Walbot, eds., Springer, New York (1994); Corn and Corn Improvement, 3^rdedition, Chapter 6, Sprague and Dudley, eds., American Society of Agronomy, Madison, Wis. (1988). A typical step in promoter isolation methods is identification of gene products that are expressed with some degree of specificity in the target tissue. Amongst the range of methodologies are: differential hybridization to cDNA libraries; subtractive hybridization; differential display; differential 2-D protein gel electrophoresis; DNA probe arrays; and isolation of proteins known to be expressed with some specificity in the target tissue. Such methods are well known to those of skill in the art. Commercially available products for identifying promoters are known in the art such as Clontech's (Palo Alto, Calif.) Universal GenomeWalker Kit.
For the protein-based methods, it is helpful to obtain the amino acid sequence for at least a portion of the identified protein, and then to use the protein sequence as the basis for preparing a nucleic acid that can be used as a probe to identify either genomic DNA directly, or preferably, to identify a cDNA clone from a library prepared from the target tissue. Once such a cDNA clone has been identified, that sequence can be used to identify the sequence at the 5′ end of the transcript of the indicated gene. For differential hybridization, subtractive hybridization and differential display, the nucleic acid sequence identified as enriched in the target tissue is used to identify the sequence at the 5′ end of the transcript of the indicated gene. Once such sequences are identified, starting either from protein sequences or nucleic acid sequences, any of these sequences identified as being from the gene transcript can be used to screen a genomic library prepared from the target organism. Methods for identifying and confirming the transcriptional start site are well known in the art. [0063]
In the process of isolating promoters expressed under particular environmental conditions or stresses, or in specific tissues, or at particular developmental stages, a number of genes are identified that are expressed under the desired circumstances, in the desired tissue, or at the desired stage. Further analysis will reveal expression of each particular gene in one or more other tissues of the plant. One can identify a promoter with activity in the desired tissue or condition but that do not have activity in any other common tissue. [0064]
To identify the promoter sequence, the 5′ portions of the clones described here are analyzed for sequences characteristic of promoter sequences. For instance, promoter sequence elements include the TATA box consensus sequence (TATAAT), which is usually an AT-rich stretch of 5-10 bp located approximately 20 to 40 base pairs upstream of the transcription start site. Identification of the TATA box is well known in the art. For example, one way to predict the location of this element is to identify the transcription start site using standard RNA-mapping techniques such as primer extension, S1 analysis, and/or RNase protection. To confirm the presence of the AT-rich sequence, a structure-function analysis can be performed involving mutagenesis of the putative region and quantification of the mutation's effect on expression of a linked downstream reporter gene. See, e.g., [0065] The Maize Handbook, Chapter 114, Freeling and Walbot, eds., Springer, New York (1994).
In plants, further upstream from the TATA box, at positions −80 to −100, there is typically a promoter element (i.e., the CAAT box) with a series of adenines surrounding the trinucleotide G (or T) N G. J. Messing et al., in [0066] Genetic Engineering in Plants, Kosage, Meredith and Hollaender, eds., pp. 221-227 (1983). In maize, there no well-conserved CAAT box but there are several short, conserved protein-binding motifs upstream of the TATA box. These include motifs for the transacting transcription factors involved in light regulation, anaerobic induction, hormonal regulation, or anthocyanin biosynthesis, as appropriate for each gene.
Once promoter and/or gene sequences are known, a region of suitable size is selected from the genomic DNA that is 5′ to the transcriptional start, or the translational start site, and such sequences are then linked to a coding sequence. If the transcriptional start site is used as the point of fusion, any of a number of possible 5′ untranslated regions can be used in between the transcriptional start site and the partial coding sequence. If the translational start site at the 3′ end of the specific promoter is used, then it is linked directly to the methionine start codon of a coding sequence. [0067]
If polypeptide expression is desired, it is generally desirable to include a polyadenylation region at the 3′-end of a polynucleotide coding region. The polyadenylation region can be derived from the natural gene, from a variety of other plant genes, or from T-DNA. The 3′ end sequence to be added can be derived from, example, the nopaline synthase or octopine synthase genes, or alternatively from another plant gene, or less preferably from any other eukaryotic gene. [0068]
An intron sequence can be added to the 5′ untranslated region or the coding sequence of the partial coding sequence to increase the amount of the mature message that accumulates in the cytosol. Inclusion of a spliceable intron in the transcription unit in both plant and animal expression constructs has been shown to increase gene expression at both the mRNA and protein levels up to 1000-fold. Buchman et al. (1988) [0069] Mol. Cell Biol. 8:4395-4405; Callis et al. (1987) Genes Dev. 1:1183-1200. Such intron enhancement of gene expression is typically greatest when placed near the 5′ end of the transcription unit. Use of maize introns Adhl- S intron 1, 2, and 6, the Bronze-I intron are known in the art. See generally, The Maize Handbook, Chapter 116, Freeling and Walbot, eds., Springer, New York (1994).
The vector comprising the sequences from a polynucleotide of the present invention could comprise a selectable marker gene for the selection of transformed cells or tissues. Selectable marker genes include genes encoding antibiotic resistance, such as those encoding neomycin phosphotransferase II (NEO) and hygromycin phosphotransferase (HPT), as well as genes conferring resistance to herbicidal compounds, such as glufosinate ammonium, bromoxynil, imidazolinones, and 2,4-dichlorophenoxyacetate (2,4-D). See generally, Yarranton (1992) [0070] Curr. Opin. Biotech. 3:506-511; Christopherson et al. (1992) Proc. Natl. Acad. Sci. USA 89:6314-6318; Yao et al. (1992) Cell 71:63-72; Reznikoff (1992) Mol. Microbiol. 6:2419-2422; Barkley et al. (1980) in The Operon, pp. 177-220; Hu et al. (1987) Cell 48:555-566; Brown et al. (1987) Cell 49:603-612; Figge et al. (1988) Cell 52:713-722; Deuschle et al. (1989) Proc. Natl. Acad. Aci. USA 86:5400-5404; Fuerst et al. (1989) Proc. Natl. Acad. Sci. USA 86:2549-2553; Deuschle et al. (1990) Science 248:480-483; Gossen (1993) Ph.D. Thesis, University of Heidelberg; Reines et al. (1993) Proc. Natl. Acad. Sci. USA 90:1917-1921; Labow et al. (1990) Mol. Cell. Biol. 10:3343-3356; Zambretti et al. (1992) Proc. Natl. Acad. Sci. USA 89:3952-3956; Baim et al. (1991) Proc. Natl. Acad. Sci. USA 88:5072-5076; Wyborski et al. (1991) Nucleic Acids Res. 19:4647-4653; Hillenand-Wissman (1989) Topics Mol. Struc. Biol. 10:143-162; Degenkolb et al. (1991) Antimicrob. Agents Chemother. 35:1591-1595; Kleinschmidt et al. (1988) Biochemistry 27:1094-1104; Bonin (1993) Ph.D. Thesis, University of Heidelberg; Gossen et al. (1992) Proc. Natl. Acad. Sci. USA 89:5547-5551; Oliva et al. (1992) Antimicrob. Agents Chemother. 36:913-919; Hlavka et al. (1985) Handbook of Experimental Pharmacology, Vol. 78 (Springer-Verlag, Berlin); Gill et al. (1988) Nature 334:721-724. Such disclosures are herein incorporated by reference.
The above list of selectable marker genes is not meant to be limiting. Any selectable marker gene can be used in the present invention. [0071]
Typical vectors useful for expression of genes in higher plants are well known in the art and include vectors derived from the tumor-inducing (Ti) plasmid of [0072] Agrobacterium tumefaciens described by Rogers et al. (1987) Meth. in Enzymol. 153:253-277. These vectors are plant integrating vectors in that on transformation, the vectors integrate a portion of vector DNA into the genome of the host plant. Exemplary A. tumefaciens vectors useful herein are plasmids pKYLX6 and pKYLX7 of Schardl et al. (1987) Gene 61:1-11 and Berger et al. (1989) Proc. Natl. Acad. Sci. (USA) 86:8402-8406. Another useful vector herein is plasmid pBI101.2 that is available from Clontech Laboratories, Inc. (Palo Alto, Calif.).
As discussed above, a polynucleotide of the present invention can be expressed in either sense or antisense orientation as desired. It will be appreciated that control of gene expression in either sense or antisense orientation can have a direct impact on the observable plant characteristics. Antisense technology can be conveniently used for gene expression in plants. To accomplish this, a nucleic acid segment from the desired gene is cloned and operably linked to a promoter such that the antisense strand of RNA will be transcribed. The construct is then transformed into plants and the antisense strand of RNA is produced. In plant cells, it has been shown that antisense RNA inhibits gene expression by preventing the accumulation of mRNA which encodes the enzyme of interest, see, e.g., Sheehy et al. (1988) [0073] Proc. Natl. Acad. Sci. (USA) 85:8805-8809; and Hiatt et al., U.S. Pat. No. 4,801,340.
In the methods of the invention, it is recognized that the entire coding sequence for the RPA construct may be utilized. Alternatively, portions or fragments of the sequence may be used in DNA constructs. [0074]
Fragments and variants of the disclosed nucleotide sequences and proteins encoded thereby are encompassed by the present invention. By “fragment” is intended a portion of the nucleotide sequence or a portion of the amino acid sequence and hence protein encoded thereby. Fragments of a nucleotide sequence may encode protein fragments that retain the biological activity of the native protein and hence modulate DNA metabolism. Alternatively, fragments of a nucleotide sequence that are useful as hybridization probes generally do not encode fragment proteins retaining biological activity. Thus, fragments of a nucleotide sequence may range from at least about 20 nucleotides, about 50 nucleotides, about 100 nucleotides, and up to the full-length nucleotide sequence encoding the proteins of the invention. [0075]
A fragment of a RPA nucleotide sequence that encodes a biologically active portion of a RPA protein of the invention will encode at least 15, 25, 30, 50, 100, 150, 200, or 250 contiguous amino acids, or up to the total number of amino acids present in a full-length RPA protein of the invention (for example, 623, 617, 273, 273, 273, 318, 273, 273 amino acids for SEQ ID NOs: 2, 4, 12, 14, 16, 18, 20, and 22 respectively. Fragments of a RPA nucleotide sequence that are useful as hybridization probes for PCR primers generally need not encode a biologically active portion of a RPA protein. [0076]
Thus, a fragment of a RPA nucleotide sequence may encode a biologically active portion of a RPA protein, or it may be a fragment that can be used as a hybridization probe or PCR primer using methods disclosed below. A biologically active portion of a RPA protein can be prepared by isolating a portion of one of the RPA nucleotide sequences of the invention, expressing the encoded portion of the RPA protein (e.g., by recombinant expression in vitro), and assessing the activity of the encoded portion of the RPA protein. Nucleic acid molecules that are fragments of a RPA nucleotide sequence comprise at least 16, 20, 50, 75, 100, 150, 200, 250, 300, 350, 400, 450, 500, 550, 600, 650, 700, 800, 900, 1,000 nucleotides, or up to the number of nucleotides present in a full-length RPA nucleotide sequence disclosed herein (for example, 2497, 2202, 1124, 979, 1051, 1087, 1074, and 1231 nucleotides for SEQ ID NOs: 1, 3, 11, 13, 15, 17, 19, and 21 respectively. [0077]
By “variants” is intended substantially similar sequences. For nucleotide sequences, conservative variants include those sequences that, because of the degeneracy of the genetic code, encode the amino acid sequence of one of the RPA polypeptides of the invention. Such naturally occurring variants including naturally occurring allelic variants, can be identified with the use of well-known molecular biology techniques, as, for example, with polymerase chain reaction (PCR) and hybridization techniques as outlined below. Variant nucleotide sequences also include synthetically derived nucleotide sequences, such as those generated, for example, by using site-directed mutagenesis but which still encode a RPA protein of the invention. Generally, variants of a particular nucleotide sequence of the invention will have at least 40%, 50%, 60%, 70%, generally at least 75%, 80%, 85%, preferably about 90% to 95% or more, and more preferably about 98% or more sequence identity to that particular nucleotide sequence as determined by sequence alignment programs described elsewhere herein using default parameters. [0078]
By “variant” protein is intended a protein derived from the native protein by deletion (so-called truncation) or addition of one or more amino acids to the N-terminal and/or C-terminal end of the native protein; deletion or addition of one or more amino acids at one or more sites in the native protein; or substitution of one or more amino acids at one or more sites in the native protein. Variant proteins encompassed by the present invention are biologically active, that is they continue to possess the desired biological activity of the native protein, that is, modulating DNA metabolism as described herein. Such variants may result from, for example, genetic polymorphism or from human manipulation. Biologically active variants of a native RPA protein of the invention will have at least 40%, 50%, 60%, 70%, generally at least 75%, 80%, 85%, preferably about 90% to 95% or more, and more preferably about 98% or more sequence identity to the amino acid sequence for the native protein as determined by sequence alignment programs described elsewhere herein using default parameters. A biologically active variant of a protein of the invention may differ from that protein by as few as 1-15 amino acid residues, as few as 1-10, such as 6-10, as few as 5, as few as 4, 3, 2, or even 1 amino acid residue. [0079]
The proteins of the invention may be altered in various ways including amino acid substitutions, deletions, truncations, and insertions. Methods for such manipulations are generally known in the art. For example, amino acid sequence variants of the RPA proteins can be prepared by mutations in the DNA. Methods for mutagenesis and nucleotide sequence alterations are well known in the art. See, for example, Kunkel (1985) [0080] Proc. Natl. Acad. Sci. USA 82:488-492; Kunkel et al. (1987) Methods in Enzymol. 154:367-382; U.S. Pat. No. 4,873,192; Walker and Gaastra, eds. (1983) Techniques in Molecular Biology (MacMillan Publishing Company, New York) and the references cited therein. Guidance as to appropriate amino acid substitutions that do not affect biological activity of the protein of interest may be found in the model of Dayhoff et al. (1978) Atlas of Protein Sequence and Structure (Natl. Biomed. Res. Found., Washington, D.C.), herein incorporated by reference. Conservative substitutions, such as exchanging one amino acid with another having similar properties, may be preferred.
Thus, the genes and nucleotide sequences of the invention include both the naturally occurring sequences as well as mutant forms. Likewise, the proteins of the invention encompass both naturally occurring proteins as well as variations and modified forms thereof. Such variants will continue to possess the desired activity in influencing DNA metabolism. Obviously, the mutations that will be made in the DNA encoding the variant must not place the sequence out of reading frame and preferably will not create complementary regions that could produce secondary mRNA structure. See, EP Patent Application Publication No. 75,444. [0081]
The deletions, insertions, and substitutions of the protein sequence encompassed herein are not expected to produce radical changes in the characteristics of the protein. However, when it is difficult to predict the exact effect of the substitution, deletion, or insertion in advance of doing so, one skilled in the art will appreciate that the effect will be evaluated by routine screening assays. That is, the activity can be evaluated by assessing DNA binding, recombination, repair and replication. See, for example, Braun et al. (1997) [0082] Biochemistry 36:8443-8454; Longhese et al. (1994) Molecular and Cellular Biology 14:7884-7890; Stigger et al. (1998) J. Biol. Chem. 273:9337-9343; Abremova et al. (1997) Proc. Natl. Acad. Sci. USA 94:7186-7191; New et al. (1998) Nature 391:407-410; Bochkareva et al. (1998) J. Biol. Chem. 273(7):3932-6; Mass et al. (1998) Mol. Cell. Biol. 18(11):6399-407; Lavrik et al. (1998) Nucleic Acids Res 26(2):602-7; Sibenaller et al. (1998) 37(36):12496-506; Matsunaga et al. (1996) J. Biol. Chem. 271 (19):11047-50; and Sung (1997) Genes & Development 11:1111-21, herein incorporated by reference.
Variant nucleotide sequences and proteins also encompass nucleotide sequences and proteins derived from a mutagenic and recombinogenic procedure such as DNA shuffling. With such a procedure, one or more different RPA coding sequences can be manipulated to create a new RPA possessing the desired properties. In this manner, libraries of recombinant polynucleotides are generated from a population of related sequence polynucleotides comprising sequence regions that have substantial sequence identity and can be homologously recombined in vitro or in vivo. For example, using this approach, sequence motifs encoding a domain of interest may be shuffled between the RPA gene of the invention and other known RPA genes to obtain a new gene coding for a protein with an improved property of interest, such as an increased Km in the case of an enzyme. Strategies for such DNA shuffling are known in the art. See, for example, Stemmer (1994) [0083] Proc. Natl. Acad. Sci. USA 91:10747-10751; Stemmer (1994) Nature 370:389-391; Crameri et al. (1997) Nature Biotech. 15:436-438; Moore et al. (1997) J. Mol. Biol. 272:336-347; Zhang et al. (1997) Proc. Natl. Acad. Sci. USA 94:4504-4509; Crameri et al. (1998) Nature 391:288-291; and U.S. Pat. Nos. 5,605,793 and 5,837,458.
It is recognized that with these nucleotide sequences, antisense constructions, complementary to at least a portion of the messenger RNA (mRNA) for the RPA sequences can be constructed. Antisense nucleotides are constructed to hybridize with the corresponding mRNA. Modifications of the antisense sequences may be made as long as the sequences hybridize to and interfere with expression of the corresponding mRNA. In this manner, antisense constructions having 70%, preferably 80%, more preferably 85% sequence similarity to the corresponding antisense sequences may be used. Furthermore, portions of the antisense nucleotides may be used to disrupt the expression of the target gene. Generally, sequences of at least 50 nucleotides, 100 nucleotides, 200 nucleotides, or greater may be used. [0084]
The nucleotide sequences of the present invention may also be used in the sense orientation to suppress the expression of endogenous genes in plants. Methods for suppressing gene expression in plants using nucleotide sequences in the sense orientation are known in the art. The methods generally involve transforming plants with a DNA construct comprising a promoter that drives expression in a plant operably linked to at least a portion of a nucleotide sequence that corresponds to the transcript of the endogenous gene. Typically, such a nucleotide sequence has substantial sequence identity to the sequence of the transcript of the endogenous gene, preferably greater than about 65% sequence identity, more preferably greater than about 85% sequence identity, most preferably greater than about 95% sequence identity. See, U.S. Pat. Nos. 5,283,184 and 5,034,323; herein incorporated by reference. [0085]
Use of the polypeptides and proteins, and fragments and variants thereof, for producing antibodies are also encompassed by the invention. The invention also encompasses using such antibodies to determine RPA protein levels, and to modulate one or more biological activities or interactions of RPA. Methods for the production of antibodies are known in the art. See, for example, Harlow and Lane, antibodies, A Laboratory Manual, Cold Spring Harbor Publications, New York (1988); and the reference is cited therein. [0086]
The RPA sequences of the invention may be optimized for enhanced expression in plants of interest. See, for example, EPA0359472; WO91/16432; Perlak et al. (1991) [0087] Proc. Natl. Acad. Sci. USA 88:3324-3328; and Murray et al. (1989) Nucleic Acids Res. 17:477-498. In this manner, the genes can be synthesized utilizing plant-preferred codons. See, for example, Murray et al. (1989) Nucleic Acids Res. 17:477-498, the disclosure of which is incorporated herein by reference. In this manner, synthetic genes can also be made based on the distribution of codons a particular host uses for a particular amino acid. Thus, the nucleotide sequences can be optimized for expression in any plant. It is recognized that all or any part of the gene sequence may be optimized or synthetic. That is, synthetic or partially optimized sequences may also be used.
Thus nucleotide sequences of the invention and the proteins encoded thereby include the native forms as well as variants thereof. The variant proteins will be substantially homologous and functionally equivalent to the native proteins. A variant of a native protein is “substantially homologous” to the native protein when at least about 80%, more preferably at least about 90%, and most preferably at least about 95% of its amino acid sequence is identical to the amino acid sequence of the native protein. By “functionally equivalent” is intended that the sequence of the variant defines a chain that produces a protein having substantially the same biological effect as the native protein of interest. Such functionally equivalent variants that comprise substantial sequence variations are also encompassed by the invention. [0088]
The nucleotide sequences of the invention can be used to isolate corresponding sequences from other organisms, particularly other plants, more particularly other monocots. In this manner, methods such as PCR, hybridization, and the like can be used to identify such sequences based on their sequence homology to the sequence set forth herein. Sequences isolated based on their sequence identity to the entire RPA sequences set forth herein or to fragments thereof are encompassed by the present invention. [0089]
In a PCR approach, oligonucleotide primers can be designed for use in PCR reactions to amplify corresponding DNA sequences from cDNA or genomic DNA extracted from any plant of interest. Methods for designing PCR primers and PCR cloning are generally known in the art and are disclosed in Sambrook et al. (1989) [0090] Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y.). See also Innis et al., eds. (1990) PCR Protocols: A Guide to Methods and Applications (Academic Press, New York); Innis and Gelfand, eds. (1995) PCR Strategies (Academic Press, New York); and Innis and Gelfand, eds. (1999) PCR Methods Manual (Academic Press, New York). Known methods of PCR include, but are not limited to, methods using paired primers, nested primers, single specific primers, degenerate primers, gene-specific primers, vector-specific primers, partially-mismatched primers, and the like.
In hybridization techniques, all or part of a known nucleotide sequence is used as a probe that selectively hybridizes to other corresponding nucleotide sequences present in a population of cloned genomic DNA fragments or cDNA fragments (i.e., genomic or cDNA libraries) from a chosen organism. The hybridization probes may be genomic DNA fragments, cDNA fragments, RNA fragments, or other oligonucleotides, and may be labeled with a detectable group such as [0091] ³²P, or any other detectable marker. Thus, for example, probes for hybridization can be made by labeling synthetic oligonucleotides based on the RPA sequences of the invention. Methods for preparation of probes for hybridization and for construction of cDNA and genomic libraries are generally known in the art and are disclosed in Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y.).
For example, the entire RPA sequence disclosed herein, or one or more portions thereof, may be used as a probe capable of specifically hybridizing to corresponding RPA sequences and messenger RNAs. To achieve specific hybridization under a variety of conditions, such probes include sequences that are unique among RPA sequences and are preferably at least about 10 nucleotides in length, and most preferably at least about 20 nucleotides in length. Such probes may be used to amplify corresponding RPA sequences from a chosen plant by PCR. This technique may be used to isolate additional coding sequences from a desired plant or as a diagnostic assay to determine the presence of coding sequences in a plant Hybridization techniques include hybridization screening of plated DNA libraries (either plaques or colonies; see, for example, Sambrook et al. (1989) [0092] Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y.).
Hybridization of such sequences may be carried out under stringent conditions. By “stringent conditions” or “stringent hybridization conditions” is intended conditions under which a probe will hybridize to its target sequence to a detectably greater degree than to other sequences (e.g., at least 2-fold over background). Stringent conditions are sequence-dependent and will be different in different circumstances. By controlling the stringency of the hybridization and/or washing conditions, target sequences that are 100% complementary to the probe can be identified (homologous probing). Alternatively, stringency conditions can be adjusted to allow some mismatching in sequences so that lower degrees of similarity are detected (heterologous probing). Generally, a probe is less than about 1000 nucleotides in length, preferably less than 500 nucleotides in length. [0093]
Typically, stringent conditions will be those in which the salt concentration is less than about 1.5 M Na ion, typically about 0.01 to 1.0 M Na ion concentration (or other salts) at pH 7.0 to 8.3 and the temperature is at least about 30° C. for short probes (e.g., 10 to 50 nucleotides) and at least about 60° C. for long probes (e.g., greater than 50 nucleotides). Stringent conditions may also be achieved with the addition of destabilizing agents such as formamide. Exemplary low stringency conditions include hybridization with a buffer solution of 30 to 35% formamide, 1 M NaCl, 1% SDS (sodium dodecyl sulphate) at 37° C., and a wash in 1×to 2×SSC (20×SSC=3.0 M NaCl/0.3 M trisodium citrate) at 50 to 55° C. Exemplary moderate stringency conditions include hybridization in 40 to 45% formamide, 1.0 M NaCl, 1% SDS at 37° C., and a wash in 0.5×to 1×SSC at 55 to 60° C. Exemplary high stringency conditions include hybridization in 50% formamide, 1 M NaCl, 1% SDS at 37° C., and a wash in 0.1×SSC at 60 to 65° C. [0094]
Specificity is typically the function of post-hybridization washes, the critical factors being the ionic strength and temperature of the final wash solution. For DNA-DNA hybrids, the Tm can be approximated from the equation of Meinkoth and Wahl (1984) [0095] Anal. Biochem. 138:267-284: T_m=81.5° C.+16.6 (log M)+0.41 (% GC)−0.61 (% form)−500/L; where M is the molarity of monovalent cations, % GC is the percentage of guanosine and cytosine nucleotides in the DNA, % form is the percentage of formamide in the hybridization solution, and L is the length of the hybrid in base pairs. The T_mis the temperature (under defined ionic strength and pH) at which 50% of a complementary target sequence hybridizes to a perfectly matched probe. T_mis reduced by about 1° C. for each 1% of mismatching; thus, T_m, hybridization, and/or wash conditions can be adjusted to hybridize to sequences of the desired identity. For example, if sequences with ≧90% identity are sought, the T_mcan be decreased 10° C. Generally, stringent conditions are selected to be about 5° C. lower than the thermal melting point (T_m) for the specific sequence and its complement at a defined ionic strength and pH. However, severely stringent conditions can utilize a hybridization and/or wash at 1, 2, 3, or 4° C. lower than the thermal melting point (T_m); moderately stringent conditions can utilize a hybridization and/or wash at 6, 7, 8, 9, or 10° C. lower than the thermal melting point (T_m); low stringency conditions can utilize a hybridization and/or wash at 11, 12, 13, 14, 15, or 20° C. lower than the thermal melting point (T_m). Using the equation, hybridization and wash compositions, and desired T_m, those of ordinary skill will understand that variations in the stringency of hybridization and/or wash solutions are inherently described. If the desired degree of mismatching results in a Tm of less than 45° C. (aqueous solution) or 32° C. (formamide solution), it is preferred to increase the SSC concentration so that a higher temperature can be used. An extensive guide to the hybridization of nucleic acids is found in Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology-Hybridization with Nucleic Acid Probes, Part I, Chapter 2 (Elsevier, New York); and Ausubel et al., eds. (1995) Current Protocols in Molecular Biology, Chapter 2 (Greene Publishing and Wiley-Interscience, New York). See Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual (2d ed., Cold Spring Harbor Laboratory Press, Plainview, N.Y.).
Thus, isolated sequences that have promoter activity or encode for a RPA protein and which hybridize under stringent conditions to the RPA sequences disclosed herein, or to fragments thereof, are encompassed by the present invention. Such sequences will be at least 40% to 50% homologous, about 60% to 70% homologous, and even about 75%, 80%, 85%, 90%, 95% to 98% homologous or more with the disclosed sequences. That is, the sequence identity of sequences may range, sharing at least 40% to 50%, about 60% to 70%, and even about 75%, 80%, 85%, 90%, 95% to 98% or more sequence identity. [0096]
The following terms are used to describe the sequence relationships between two or more nucleic acids or polynucleotides: (a) “reference sequence”, (b) “comparison window”, (c) “sequence identity”, (d) “percentage of sequence identity”, and (e) “substantial identity”. [0097]
(a) As used herein, “reference sequence” is a defined sequence used as a basis for sequence comparison. A reference sequence may be a subset or the entirety of a specified sequence; for example, as a segment of a full-length cDNA or gene sequence, or the complete cDNA or gene sequence. [0098]
(b) As used herein, “comparison window” makes reference to a contiguous and specified segment of a polynucleotide sequence, wherein the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. Generally, the comparison window is at least 20 contiguous nucleotides in length, and optionally can be 30, 40, 50, 100, or longer. Those of skill in the art understand that to avoid a high similarity to a reference sequence due to inclusion of gaps in the polynucleotide sequence a gap penalty is typically introduced and is subtracted from the number of matches. [0099]
Methods of alignment of sequences for comparison are well known in the art. Thus, the determination of percent identity between any two sequences can be accomplished using a mathematical algorithm. Preferred, non-limiting examples of such mathematical algorithms are the algorithm of Myers and Miller (1988) [0100] CABIOS 4:11-17; the local homology algorithm of Smith et al. (1981) Adv. Appl. Math. 2:482; the homology alignment algorithm of Needleman and Wunsch (1970) J. Mol. Biol. 48:443-453; the search-for-similarity-method of Pearson and Lipman (1988) Proc. Natl. Acad. Sci. 85:2444-2448; the algorithm of Karlin and Altschul (1990) Proc. Natl. Acad. Sci. USA 872264, modified as in Karlin and Altschul (1993) Proc. Natl. Acad. Sci. USA 90:5873-5877.
Computer implementations of these mathematical algorithms can be utilized for comparison of sequences to determine sequence identity. Such implementations include, but are not limited to: CLUSTAL in the PC/Gene program (available from Intelligenetics, Mountain View, Calif.); the ALIGN program (Version 2.0) and GAP, BESTFIT, BLAST, FASTA, and TFASTA in the Wisconsin Genetics Software Package, Version 8 (available from Genetics Computer Group (GCG), 575 Science Drive, Madison, Wis., USA). Alignments using these programs can be performed using the default parameters. The CLUSTAL program is well described by Higgins et al. (1988) [0101] Gene 73:237-244 (1988); Higgins et al. (1989) CABIOS 5:151-153; Corpet et al. (1988) Nucleic Acids Res. 16:10881-90; Huang et al. (1992) CABIOS 8:155-65; and Pearson et al. (1994) Meth. Mol. Biol. 24:307-331. The ALIGN program is based on the algorithm of Myers and Miller (1988) supra. A PAM120 weight residue table, a gap length penalty of 12, and a gap penalty of 4 can be used with the ALIGN program when comparing amino acid sequences. The BLAST programs of Altschul et al (1990) J. Mol. Biol. 215:403 are based on the algorithm of Karlin and Altschul (1990) supra. BLAST nucleotide searches can be performed with the BLASTN program, score=100, wordlength=12, to obtain nucleotide sequences homologous to a nucleotide sequence encoding a protein of the invention. BLAST protein searches can be performed with the BLASTX program, score=50, wordlength=3, to obtain amino acid sequences homologous to a protein or polypeptide of the invention. To obtain gapped alignments for comparison purposes, Gapped BLAST (in BLAST 2.0) can be utilized as described in Altschul et al. (1997) Nucleic Acids Res. 25:3389. Alternatively, PSI-BLAST (in BLAST 2.0) can be used to perform an iterated search that detects distant relationships between molecules. See Altschul et al. (1997) supra. When utilizing BLAST, Gapped BLAST, PSI-BLAST, the default parameters of the respective programs (e.g., BLASTN for nucleotide sequences, BLASTX for proteins) can be used. See www.ncbi.nlm.nih.gov. Alignment may also be performed manually by inspection. Alignment may also be performed manually by inspection.
For purposes of the present invention, comparison of nucleotide or protein sequences for determination of percent sequence identity to the RPA sequences disclosed herein is preferably made using the GCG PileUp program, version 10.00, with its default parameters or any equivalent program. By “equivalent program” is intended any sequence comparison program that, for any two sequences in question, generates an alignment having identical nucleotide or amino acid residue matches and an identical percent sequence identity when compared to the corresponding alignment generated by the preferred program. [0102]
(c) As used herein, “sequence identity” or “identity” in the context of two nucleic acid or polypeptide sequences makes reference to the residues in the two sequences that are the same when aligned for maximum correspondence over a specified comparison window. When percentage of sequence identity is used in reference to proteins it is recognized that residue positions which are not identical often differ by conservative amino acid substitutions, where amino acid residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. When sequences differ in conservative substitutions, the percent sequence identity may be adjusted upwards to correct for the conservative nature of the substitution. Sequences that differ by such conservative substitutions are said to have “sequence similarity” or “similarity”. Means for making this adjustment are well known to those of skill in the art. Typically this involves scoring a conservative substitution as a partial rather than a full mismatch, thereby increasing the percentage sequence identity. Thus, for example, where an identical amino acid is given a score of 1 and a non-conservative substitution is given a score of zero, a conservative substitution is given a score between zero and 1. The scoring of conservative substitutions is calculated, e.g., as implemented in the program PC/GENE (Intelligenetics, Mountain View, Calif.). [0103]
(d) As used herein, “percentage of sequence identity” means the value determined by comparing two optimally aligned sequences over a comparison window, wherein the portion of the polynucleotide sequence in the comparison window may comprise additions or deletions (i.e., gaps) as compared to the reference sequence (which does not comprise additions or deletions) for optimal alignment of the two sequences. The percentage is calculated by determining the number of positions at which the identical nucleic acid base or amino acid residue occurs in both sequences to yield the number of matched positions, dividing the number of matched positions by the total number of positions in the window of comparison, and multiplying the result by 100 to yield the percentage of sequence identity. [0104]
(e)(i) The term “substantial identity” of polynucleotide sequences means that a polynucleotide comprises a sequence that has at least 70% sequence identity, preferably at least 80%, more preferably at least 90%, and most preferably at least 95%, compared to a reference sequence using one of the alignment programs described using standard parameters. One of skill in the art will recognize that these values can be appropriately adjusted to determine corresponding identity of proteins encoded by two nucleotide sequences by taking into account codon degeneracy, amino acid similarity, reading frame positioning, and the like. Substantial identity of amino acid sequences for these purposes normally means sequence identity of at least 60%, more preferably at least 70%, 80%, 90%, and most preferably at least 95%. [0105]
Another indication that nucleotide sequences are substantially identical is if two molecules hybridize to each other under stringent conditions. Generally, stringent conditions are selected to be about 5° C. lower than the thermal melting point (T[0106] _m) for the specific sequence at a defined ionic strength and pH. However, stringent conditions encompass temperatures in the range of about 1° C. to about 20° C., depending upon the desired degree of stringency as otherwise qualified herein. Nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the polypeptides they encode are substantially identical. This may occur, e.g., when a copy of a nucleic acid is created using the maximum codon degeneracy permitted by the genetic code. One indication that two nucleic acid sequences are substantially identical is when the polypeptide encoded by the first nucleic acid is immunologically cross reactive with the polypeptide encoded by the second nucleic acid.
(e)(ii) The term “substantial identity” in the context of a peptide indicates that a peptide comprises a sequence with at least 70% sequence identity to a reference sequence, preferably 80%, more preferably 85%, most preferably at least 90% or 95% sequence identity to the reference sequence over a specified comparison window. Preferably, optimal alignment is conducted using the homology alignment algorithm of Needleman et al. (1970) [0107] J. Mol. Biol. 48:443. An indication that two peptide sequences are substantially identical is that one peptide is immunologically reactive with antibodies raised against the second peptide. Thus, a peptide is substantially identical to a second peptide, for example, where the two peptides differ only by a conservative substitution. Peptides that are “substantially similar” share sequences as noted above except that residue positions that are not identical may differ by conservative amino acid changes.
Using the nucleic acids of the present invention, one may express a protein of the present invention in a recombinantly engineered cell such as bacteria, yeast, insect, mammalian, or preferably plant cells. The cells produce the protein in a non-natural condition (e.g., in quantity, composition, location, and/or time), because they have been genetically altered through human intervention to do so. [0108]
It is expected that those of skill in the art are knowledgeable in the numerous expression systems available for expression of a nucleic acid encoding a protein of the present invention. No attempt to describe in detail the various methods known for the expression of proteins in prokaryotes or eukaryotes will be made. [0109]
In brief summary, the expression of isolated nucleic acids encoding a protein of the present invention will typically be achieved by operably linking, for example, the DNA or cDNA to a promoter (which is either constitutive or inducible), followed by incorporation into an expression vector. The vectors can be suitable for replication and integration in either prokaryotes or eukaryotes. Typical expression vectors contain transcription and translation terminators, initiation sequences, and promoters useful for regulation of the expression of the DNA encoding a protein of the present invention. To obtain high level expression of a cloned gene, it is desirable to construct expression vectors which contain, at the minimum, a strong promoter to direct transcription, a ribosome binding site for translational initiation, and a transcription/translation terminator. One of skill would recognize that modifications can be made to a protein of the present invention without diminishing its biological activity. Some modifications may be made to facilitate the cloning, expression, or incorporation of the targeting molecule into a fusion protein. Such modifications are well known to those of skill in the art and include, for example, a methionine added at the amino terminus to provide an initiation site, or additional amino acids (e.g., poly His) placed on either terminus to create conveniently located restriction sites or termination codons or purification sequences. [0110]
Prokaryotic cells may be used as hosts for expression. Prokaryotes most frequently are represented by various strains of [0111] E. coli; however, other microbial strains may also be used. Commonly used prokaryotic control sequences which are defined herein to include promoters for transcription initiation, optionally with an operator, along with ribosome binding site sequences, include such commonly used promoters as the beta lactamase (penicillinase) and lactose (lac) promoter systems (Chang et al. (1977) Nature 198:1056), the tryptophan (trp) promoter system (Goeddel et al. (1980) Nucleic Acids Res. 8:4057) and the lambda-derived P L promoter and N-gene ribosome binding site (Shimatake et al. (1981) Nature 292:128). The inclusion of selection markers in DNA vectors transfected in E. coli is also useful. Examples of such markers include genes specifying resistance to ampicillin, tetracycline, or chloramphenicol.
The vector is selected to allow introduction into the appropriate host cell. Bacterial vectors are typically of plasmid or phage origin. Appropriate bacterial cells are infected with phage vector particles or transfected with naked phage vector DNA. If a plasmid vector is used, the bacterial cells are transfected with the plasmid vector DNA. Expression systems for expressing a protein of the present invention are available using Bacillus sp. and Salmonella (Palva et al. (1983) [0112] Gene 22:229-235; Mosbach et al. (1983) Nature 302:543-545).
A variety of eukaryotic expression systems such as yeast, insect cell lines, plant and mammalian cells, are known to those of skill in the art. The sequences of the present invention can be expressed in these eukaryotic systems. In some embodiments, transformed/transfected plant cells are employed as expression systems for production of the proteins of the instant invention. [0113]
Synthesis of heterologous proteins in yeast is well known. Sherman, F. et al. (1982) [0114] Methods in Yeast Genetics, Cold Spring Harbor Laboratory is a well recognized work describing the various methods available to produce the protein in yeast. Two widely utilized yeast for production of eukaryotic proteins are Saccharomyces cerevisia and Pichia pastoris. Vectors, strains, and protocols for expression in Saccharomyces and Pichia are known in the art and available from commercial suppliers (e.g., Invitrogen). Suitable vectors usually have expression control sequences, such as promoters, including 3-phosphoglycerate kinase or alcohol oxidase, and an origin of replication, termination sequences and the like as desired.
A protein of the present invention, once expressed, can be isolated from yeast by lysing the cells and applying standard protein isolation techniques to the lysates. The monitoring of the purification process can be accomplished by using Western blot techniques or radioimmunoassay of other standard immunoassay techniques. [0115]
The sequences encoding proteins of the present invention can also be ligated to various expression vectors for use in transfecting cell cultures of, for instance, mammalian, insect, or plant origin. Illustrative of cell cultures useful for the production of the peptides are mammalian cells. Mammalian cell systems often will be in the form of monolayers of cells although mammalian cell suspensions may also be used. A number of suitable host cell lines capable of expressing intact proteins have been developed in the art, and include the HEK293, BHK21, and CHO cell lines. Expression vectors for these cells can include expression control sequences, such as an origin of replication, a promoter (e.g., the CMV promoter, a HSV tk promoter or pgk (phosphoglycerate kinase promoter)), an enhancer (Queen et al. (1986) [0116] Immunol. Rev. 89:49), and necessary processing information sites, such as ribosome binding sites, RNA splice sites, polyadenylation sites (e.g., an SV40 large T Ag poly A addition site), and transcriptional terminator sequences. Other animal cells useful for production of proteins of the present invention are available, for instance, from the American Type Culture Collection Catalogue of Cell Lines and Hybridomas (7th edition, 1992).
Appropriate vectors for expressing proteins of the present invention in insect cells are usually derived from the SF9 baculovirus. Suitable insect cell lines include mosquito larvae, silkworm, armyworm, moth and Drosophila cell lines such as a Schneider cell line (See Schneider et al. (1987) [0117] J. Embryol. Exp. Morphol. 27:353-365).
As with yeast, when higher animal or plant host cells are employed, polyadenylation or transcription terminator sequences are typically incorporated into the vector. An example of a terminator sequence is the polyadenylation sequence from the bovine growth hormone gene. Sequences for accurate splicing of the transcript may also be included. An example of a splicing sequence is the VP1 intron from SV40 (Sprague et al. (1983) [0118] J. Virol. 45:773-781). Additionally, gene sequences to control replication in the host cell may be incorporated into the vector such as those found in bovine papilloma virus-type vectors. Saveria-Campo, M., Bovine Papilloma Virus DNA a Eukaryotic Cloning Vector in DNA Cloning Vol. II a Practical Approach, D. M. Glover, ed., IRL Press, Arlington, Va. pp. 213-238 (1985).
The sequences of the invention can be introduced into any plant of interest, and used for transformation of any plant species. The sequences to be introduced may be used in expression cassettes for expression in the particular plant of interest. [0119]
Plants of interest include, but are not limited to corn ([0120] Zea mays), Brassica sp. (e.g., B. napus, B. rapa, B. juncea), particularly those Brassica species useful as sources of seed oil, alfalfa (Medicago sativa), rice (Oryza sativa), rye (Secale cereale), sorghum (Sorghum bicolor, Sorghum vulgare), millet (e.g., pearl millet (Pennisetum glaucum), proso millet (Panicum miliaceum), foxtail millet (Setaria italica), finger millet (Eleusine coracana)), sunflower (Helianthus annuus), safflower (Carthamus tinctorius), wheat (Triticum aestivum), soybean (Glycine max), tobacco (Nicotiana tabacum), potato (Solanum tuberosum), peanuts (Arachis hypogaea), cotton (Gossypium barbadense, Gossypium hirsutum), sweet potato (Ipomoea batatus), cassaya (Manihot esculenta), coffee (Cofea spp.), coconut (Cocos nucifera), pineapple (Ananas comosus), citrus trees (Citrus spp.), cocoa (Theobroma cacao), tea (Camellia sinensis), banana (Musa spp.), avocado (Persea americana), fig (Ficus casica), guava (Psidium guajava), mango (Mangifera indica), olive (Olea europaea), papaya (Carica papaya), cashew (Anacardium occidentale), macadamia (Macadamia integrifolia), almond (Prunus amygdalus), sugar beets (Beta vulgaris), sugarcane (Saccharum spp.), oats, barley, vegetables, ornamentals, and conifers.
Vegetables include tomatoes ([0121] Lycopersicon esculentum), lettuce (e.g., Lactuca sativa), green beans (Phaseolus vulgaris), lima beans (Phaseolus limensis), peas (Lathyrus spp.), and members of the genus Cucumis such as cucumber (C. sativus), cantaloupe (C. cantalupensis), and musk melon (C. melo). Ornamentals include azalea (Rhododendron spp.), hydrangea (Macrophylla hydrangea), hibiscus (Hibiscus rosasanensis), roses (Rosa spp.), tulips (Tulipa spp.), daffodils (Narcissus spp.), petunias (Petunia hybrida), carnation (Dianthus caryophyllus), poinsettia (Euphorbia pulcherrima), and chrysanthemum. Conifers that may be employed in practicing the present invention include, for example, pines such as loblolly pine (Pinus taeda), slash pine (Pinus elliotil), ponderosa pine (Pinus ponderosa), lodgepole pine (Pinus contorta), and Monterey pine (Pinus radiata); Douglas-fir (Pseudotsuga menziesii); Western hemlock (Tsuga canadensis); Sitka spruce (Picea glauca); redwood (Sequoia sempervirens); true firs such as silver fir (Abies amabilis) and balsam fir (Abies balsamea); and cedars such as Western red cedar (Thuja plicata) and Alaska yellow-cedar (Chamaecyparis nootkatensis). Preferably, plants of the present invention are crop plants (for example, corn, alfalfa, sunflower, Brassica, soybean, cotton, safflower, peanut, sorghum, wheat, millet, tobacco, etc.), more preferably corn and soybean plants, yet more preferably corn plants.
Plants of particular interest include grain plants that provide seeds of interest, oil-seed plants, and leguminous plants. Seeds of interest include grain seeds, such as corn, wheat, barley, rice, sorghum, rye, etc. Oil-seed plants include cotton, soybean, safflower, sunflower, Brassica, maize, alfalfa, palm, coconut, etc. Leguminous plants include beans and peas. Beans include guar, locust bean, fenugreek, soybean, garden beans, cowpea, mungbean, lima bean, fava bean, lentils, chickpea, etc. [0122]
The RPA coding and antisense sequences of the invention are provided in expression cassettes for expression in the plant of interest. The cassette will include 5′ and 3′ regulatory sequences operably linked to a RPA sequence of the invention. The cassette may additionally contain at least one additional gene to be cotransformed into the organism. Alternatively, the additional gene(s) can be provided on another expression cassette. By “operably linked” is intended a functional linkage between a promoter and a second sequence, wherein the promoter sequence initiates and mediates transcription of the DNA sequence corresponding to the second sequence. Generally, operably linked means that the nucleic acid sequences being linked are contiguous and, where necessary to join two protein coding regions, contiguous and in the same reading frame. [0123]
Such an expression cassette is provided with a plurality of restriction sites for insertion of the RPA sequence to be under the transcriptional regulation of the regulatory regions. The expression cassette may additionally contain selectable marker genes. [0124]
The expression cassette will include in the 5′-3′ direction of transcription, a transcriptional and translational initiation region, a RPA DNA sequence of the invention, and a transcriptional and translational termination region functional in plants. The transcriptional initiation region, the promoter, may be native or analogous or foreign or heterologous to the plant host. Additionally, the promoter may be the natural sequence or alternatively a synthetic sequence. By “foreign” is intended that the transcriptional initiation region is not found in the native plant into which the transcriptional initiation region is introduced. As used herein, a chimeric gene comprises a coding sequence operably linked to a transcription initiation region that is heterologous to the coding sequence. [0125]
While it may be preferable to express the sequences using heterologous promoters, the native promoter sequences may be used. Such constructs would change expression levels of RPA in the plant or plant cell. Thus, the phenotype of the plant or plant cell is altered. [0126]
The termination region may be native with the transcriptional initiation region, may be native with the operably linked DNA sequence of interest, or may be derived from another source. Convenient termination regions are available from the Ti-plasmid of [0127] A. tumefaciens, such as the octopine synthase and nopaline synthase termination regions. See also Guerineau et al. (1991) Mol. Gen. Genet 262:141-144; Proudfoot (1991) Cell 64:671-674; Sanfacon et al. (1991) Genes Dev. 5:141-149; Mogen et al. (1990) Plant Cell 2:1261-1272; Munroe et al. (1990) Gene 91:151-158; Ballas et al. (1989) Nucleic Acids Res. 17:7891-7903; and Joshi et al. (1987) Nucleic Acid Res. 15:9627-9639.
Where appropriate, the gene(s) may be optimized for increased expression in the transformed plant. That is, the genes can be synthesized using plant-preferred codons for improved expression. See, for example, Campbell and Gowri (1990) [0128] Plant Physiol. 92:1-11 for a discussion of host-preferred codon usage. Methods are available in the art for synthesizing plant-preferred genes. See, for example, U.S. Pat. Nos. 5,380,831, and 5,436,391, and Murray et al. (1989) Nucleic Acids Res. 17:477-498, herein incorporated by reference.
Additional sequence modifications are known to enhance gene expression in a cellular host. These include elimination of sequences encoding spurious polyadenylation signals, exon-intron splice site signals, transposon-like repeats, and other such well-characterized sequences that may be deleterious to gene expression. The G-C content of the sequence may be adjusted to levels average for a given cellular host, as calculated by reference to known genes expressed in the host cell. When possible, the sequence is modified to avoid predicted hairpin secondary mRNA structures. [0129]
The expression cassettes may additionally contain 5′ leader sequences in the expression cassette construct. Such leader sequences can act to enhance translation. Translation leaders are known in the art and include: picornavirus leaders, for example, EMCV leader (Encephalomyocarditis 5′ noncoding region) (Elroy-Stein et al. (1989) [0130] PNAS USA 86:6126-6130); polyvirus leaders, for example, TEV leader (Tobacco Etch Virus) (Allison et al. (1986); MDMV leader (Maize Dwarf Mosaic Virus); Virology 154:9-20), and human immunoglobulin heavy-chain binding protein (BiP), (Macejak et al. (1991) Nature 353:90-94); untranslated leader from the coat protein mRNA of alfalfa mosaic virus (AMV RNA 4) (Jobling et al. (1987) Nature 325:622-625); tobacco mosaic virus leader (TMV) (Gallie et al. (1989) in Molecular Biology of RNA, ed. Cech (Liss, New York), pp. 237-256); and maize chlorotic mottle virus leader (MCMV) (Lommel et al. (1991) Virology 81:382-385). See also, Della-Cioppa et al. (1987) Plant Physiol. 84:965-968. Other methods known to enhance translation can also be utilized, for example, introns, and the like.
In preparing the expression cassette, the various DNA fragments may be manipulated, so as to provide for the DNA sequences in the proper orientation and, as appropriate, in the proper reading frame. Toward this end, adapters or linkers may be employed to join the DNA fragments or other manipulations may be involved to provide for convenient restriction sites, removal of superfluous DNA, removal of restriction sites, or the like. For this purpose, in vitro mutagenesis, primer repair, restriction, annealing, resubstitutions, e.g., transitions and transversions, may be involved. [0131]
The sequences of the present invention can be used to transform or transfect any plant. In this manner, genetically modified plants, plant cells, plant tissue, seed, and the like can be obtained. Transformation protocols as well as protocols for introducing nucleotide sequences into plants may vary depending on the type of plant or plant cell, i.e., monocot or dicot, targeted for transformation. Suitable methods of introducing nucleotide sequences into plant cells and subsequent insertion into the plant genome include microinjection (Crossway et al. (1986) [0132] Biotechniques 4:320-334), electroporation (Riggs et al. (1986) Proc. Natl. Acad. Sci. USA 83:5602-5606, Agrobacterium-mediated transformation (Townsend et al., U.S. Pat. No. 5,563,055), direct gene transfer (Paszkowski et al. (1984) EMBO J. 3:2717-2722), and ballistic particle acceleration (see, for example, Sanford et al., U.S. Pat. No. 4,945,050; Tomes et al., U.S. Pat. No. 5,879,918; Tomes et al., U.S. Pat. No. 5,886,244; Bidney et al., U.S. Pat. No. 5,932,782; Tomes et al. (1995) “Direct DNA Transfer into Intact Plant Cells via Microprojectile Bombardment,” in Plant Cell, Tissue, and Organ Culture: Fundamental Methods, ed. Gamborg and Phillips (Springer-Verlag, Berlin); and McCabe et al. (1988) Biotechnology 6:923-926). Also see Weissinger et al. (1988) Ann. Rev. Genet. 22:421-477; Sanford et al. (1987) Particulate Science and Technology 5:27-37 (onion); Christou et al. (1988) Plant Physiol. 87:671-674 (soybean); Finer and McMullen (1991) In Vitro Cell Dev. Biol. 27P:175-182 (soybean); Singh et al. (1998) Theor. Appl. Genet. 96:319-324 (soybean); Datta et al. (1990) Biotechnology 8:736-740 (rice); Klein et al. (1988) Proc. Natl. Acad. Sci. USA 85:4305-4309 (maize); Klein et al. (1988) Biotechnology 6:559-563 (maize); Tomes, U.S. Pat. No. 5,240,855; Buising et al., U.S. Pat. Nos. 5,322,783 and 5,324,646; Klein et al. (1988) Plant Physiol. 91:440-444 (maize); Fromm et al. (1990) Biotechnology 8:833-839 (maize); Hooykaas-Van Slogteren et al. (1984) Nature (London) 311:763-764; Bowen et al., U.S. Pat. No. 5,736,369 (cereals); Bytebier et al. (1987) Proc. Natl. Acad. Sci. USA 84:5345-5349 (Liliaceae); De Wet et al. (1985) in The Experimental Manipulation of Ovule Tissues, ed. Chapman et al. (Longman, New York), pp. 197-209 (pollen); Kaeppler et al. (1990) Plant Cell Reports 9:415-418 and Kaeppler et al. (1992) Theor. Appl. Genet. 84:560-566 (whisker-mediated transformation); D'Halluin et al. (1992) Plant Cell 4:1495-1505 (electroporation); Li et al. (1993) Plant Cell Reports 12:250-255 and Christou and Ford (1995) Annals of Botany 75:407-413 (rice); Osjoda et al. (1996) Nature Biotechnology 14:745-750 (maize via Agrobacterium tumefaciens); all of which are herein incorporated by reference.
The cells that have been transformed may be grown into plants in accordance with conventional ways. See, for example, McCormick et al. (1986) [0133] Plant Cell Reports 5:81-84. These plants may then be grown, and either pollinated with the same transformed strain or different strains, and the resulting hybrid having constitutive expression of the desired phenotypic characteristic identified. Two or more generations may be grown to ensure that expression of the desired phenotypic characteristic is stably maintained and inherited and then seeds harvested to ensure expression of the desired phenotypic characteristic has been achieved.
Transgenic plants expressing the selectable marker can be screened for transmission of the nucleic acid of the present invention by, for example, standard immunoblot and DNA detection techniques. Transgenic lines are also typically evaluated on levels of expression of the heterologous nucleic acid. Expression at the RNA level can be determined initially to identify and quantitate expression-positive plants. Standard techniques for RNA analysis can be employed and include PCR amplification assays using oligonucleotide primers designed to amplify only the heterologous RNA templates and solution hybridization assays using heterologous nucleic acid-specific probes. The RNA-positive plants can then be analyzed for protein expression by Western immunoblot analysis using the specifically reactive antibodies of the present invention. In addition, in situ hybridization and immunocytochemistry according to standard protocols can be done using heterologous nucleic acid specific polynucleotide probes and antibodies, respectively, to localize sites of expression within transgenic tissue. Generally, a number of transgenic lines are usually screened for the incorporated nucleic acid to identify and select plants with the most appropriate expression profiles. [0134]
A preferred embodiment is a transgenic plant that is homozygous for the added heterologous nucleic acid; i.e., a transgenic plant that contains two added nucleic acid sequences, one gene at the same locus on each chromosome of a chromosome pair. A homozygous transgenic plant can be obtained by sexually mating (selfing) a heterozygous transgenic plant that contains a single added heterologous nucleic acid, germinating some of the seed produced and analyzing the resulting plants produced for altered RPA expression relative to a control plant (i.e., native, non-transgenic). Backcrossing to a parental plant and out-crossing with a non-transgenic plant are also contemplated. [0135]
The present invention further provides a method for modulating (i.e., increasing or decreasing) RPA levels in a plant or part thereof. Modulation can be effected by increasing or decreasing the total amount of RPA (i.e., its content) and/or the ratio of various RPA subunit proteins (i.e., its composition) in the plant. The method comprises transforming a plant cell with a recombinant expression cassette comprising a polynucleotide of the present invention as described above to obtain a transformed plant cell, growing the transformed plant cell under plant forming conditions, and inducing expression of a polynucleotide of the present invention in the plant for a time sufficient to modulate RPA content and/or composition in the plant or plant part. [0136]
In some embodiments, RPA in a plant may be modulated by altering, in vivo or in vitro, the promoter of a non-isolated RPA gene to up- or down-regulate gene expression. In some embodiments, the coding regions of native RPA genes an be altered via substitution, addition, insertion, or deletion to decrease activity of the encoded enzyme. See, e.g., Kmiec, U.S. Pat. No. 5,565,350; Zarling et al., PCT/US93/03868. And in some embodiments, an isolated nucleic acid (e.g., a vector) comprising a promoter sequence is transfected into a plant cell. Subsequently, a plant cell comprising the promoter operably linked to a polynucleotide of the present invention is selected by means known to those of skill in the art such as, but not limited to, Southern blot, DNA sequencing, or PCR analysis using primers specific to the promoter and to the gene and detecting amplicons produced therefrom. A plant or plant part altered or modified by the foregoing embodiments is grown under plant forming conditions for a time sufficient to modulate RPA content and/or composition in the plant. Plant forming conditions are well known in the art and discussed briefly, supra. [0137]
In general, content or composition is increased or decreased by at least 5%, 10%, 20%, 30%, 40%, 50%, 60%, 70%, 80%, or 90% relative to a native control plant, plant part, or cell lacking the aforementioned recombinant expression cassette. Modulation in the present invention may occur during and/or subsequent to growth of the plant to the desired stage of development. Modulating nucleic acid expression temporally and/or in particular tissues can be controlled by employing the appropriate promoter operably linked to a polynucleotide of the present invention in, for example, sense or antisense orientation as discussed in greater detail, supra. Induction of expression of a polynucleotide of the present invention can also be controlled by exogenous administration of an effective amount of inducing compound. Inducible promoters and inducing compounds that activate expression from these promoters are well known in the art. In preferred embodiments, RPA is modulated in monocots, particularly maize. [0138]
The ability of RPA to interact with multiple proteins or protein complexes allows it to participate and regulate these multiple pathways of DNA metabolism. For example, it has been shown in mammalian systems that are RPA interacts with DNA polymerase alpha (Barun et al. (1997) [0139] Biochemistry 36:8443-8454), p53 (Dutta et al. (1993) Nature 365:79-82), RAD 62 (Park et al. (1996) J. Biol. Chem. 271:18996-19000).
Participation of the middle subunit of RPA in protein-protein interactions has also been shown. Examples of such interactions include, but are not limited to interactions with XPA protein and RAD 52 (He et al. (1995) [0140] Nature 374:566-69; Matsuda et al. (1995) J. Biol. Chem. 270:4152-57; Li et al. (1995) Mol. Cell. Biol. 15:5396402, Park et al. (1996) J. Biol. Chem. 271:18996-19000); and PCNA (Shivji et al. (1995) Biochemistry 34:5011-5017).
Similarly, yeast RPA has been shown to be involved in multiple functions in DNA metabolism (Umezu et al. (1998) [0141] Genetics 148:989-1005). Therefore, the proteins of the invention may be useful as a ligand to purify and clone other proteins involved in DNA recombination, repair, and replication. Particularly, the maize proteins may be useful to purify other maize proteins involved in DNA metabolism. For example, the RPA proteins of the invention may be insolubilized on a solid matrix (e.g. agrose or nylon beads) for affinity purification, or the RPA cDNA may be used as a bait in a yeast to-hybrid system. In this manner, other proteins may be used identified and isolated.
The following examples are offered by way of illustration and not by way of limitation. [0142]

Experimental

EXAMPLE 1

cDNA Cloning

Total RNA was isolated from corn tissues with TRIzol Reagent (Life Technology, Inc. Gaithersburg, Md.) using a modification of the guanidine isothiocyanate/acid-phenol procedure described by Chomczynski and Sacchi (Chomczynski et al. (1987) [0143] Anal. Biochem. 162:156). In brief, plant tissue samples were pulverized in liquid nitrogen before the addition of the TRIzol Reagent, and then were further homogenized with a mortar and pestle. Addition of chloroform by centrifugation was conducted for separation of an aqueous phase and an organic phase. The total RNA was recovered by precipitation with isopropyl alcohol from the aqueous phase.
The selection of poly(A)+RNA from total RNA was performed using PolyATract system (Promega Corporation, Madison, Wis.). In brief, biotinylated oligo (dT) primers were used to hybridize to the 3′ poly(A) tails on mRNA. The hybrids were captured using streptavidin coupled to paramagnetic particles and a magnetic separation stand. The mRNA was washed at high stringent condition and cluted by Rnase-free deionized water. [0144]
Synthesis of the cDNA was performed and unidirectional cDNA libraries were constructed using the SuperScript Plasmid System (Life Technology, Inc., Gaithersburg, Md.). First strand of cDNA was synthesized by priming an oligo(dT) primer containing a Not I site. The reaction was catalyzed by SuperScript Reverse Transcriptase II at 45° C. The second strand of cDNA was labeled with α-32P-dCTP and portions of the molecules smaller than 500 base pairs and unligated adapters were removed by Sephacryl-S400 chromatography. The selected cDNA molecules were ligated into pSPORT1 reference vector between the Not I and Sal I sites. [0145]
Individual colonies were picked and DNA was prepared either by PCR with M13 forward primers and M13 reverse primers, or by plasmid miniprep isolation. All the cDNA clones were sequenced using M13 reverse primers. [0146]

Two maize homologues for RPA large subunit (ZmRPALSH) have been isolated. The genes map to two different chromosomes as shown below in Table 1. The amino acid and nucleotide sequences for the two homologues are set forth in SEQ ID NOs: 1-4.

TABLE 1


Maize RPA Large Subunit Genes Map to Two Different Chromosomes

Clone ID	Chromosome No.	Homologue

CBPBS68	c9	ZmRPALSH1
CCRBJ83	c9	ZmRPALSH1
CDPGS47	c9	ZmRPALSH1
CHCLE65	c9	ZmRPALSH1
CJLPL35	c9	ZmRPALSH1
COMGE67	c9	ZmRPALSH1
CBAAK06	c9	ZmRPALSH2
CDPGS46	c9	ZmRPALSH2
CERAG93	c9	ZmRPALSH2
COMFY67	c9	ZmRPALSH2

Ten ESTs, which form two different contigs for maize RPA large subunit, were used as probes for mapping experiments. Each contig represents one maize homologue for RPALS. [0148]

Seven maize homologues for RPA middle subunit (ZmRPAMSH) have been isolated. The genes map to chromosomes 5 as shown below in Table 2. The nucleotide and amino acid sequences of the seven homologues are set forth in SEQ ID NOs: 11-22.

TABLE 2


Maize Homologues of Eukaryotic Replication Protein A Middle Subunit

			Map
Clone ID	Homologue	Library	Position

CCRBK63	ZmRPAMSH-1	P0026	C5
CGEUZ26	ZmRPAMSH-2	P0002	TBD
CGEVJ74	ZmRPAMSH-3	P0002	TBD
CHSBX01	ZmRPABMS-4	P0118	C5
CIMME04	ZmRPAMSH-5	P0114	C5
CRTBB78	ZmRPAMSH-6	P0041	C5
CVRAP89	ZmRPAMSH-7	P0057	C5

EXAMPLE 2

Transformation and Regeneration of Transgenic Plants

Immature maize embryos from greenhouse donor plants are bombarded with a plasmid containing the RPA antisense sequence of the invention operably linked to a pathogen-inducible promoter (FIG. 2) plus a plasmid containing the selectable marker gene PAT (Wohlleben et al. (1988) [0150] Gene 70:25-37) that confers resistance to the herbicide Bialaphos. Transformation is performed as follows. All media recipes are in the Appendix.
Preparation of Target Tissue [0151]
The ears are surface sterilized in 30% Chlorox bleach plus 0.5% Micro detergent for 20 minutes, and rinsed two times with sterile water. The immature embryos are excised and placed embryo axis side down (scutellum side up), 25 embryos per plate, on 560Y medium for 4 hours and then aligned within the 2.5-cm target zone in preparation for bombardment. [0152]
Preparation of DNA [0153]
A plasmid vector comprising the RPA sequence of the invention operably linked to a ubiquitin promoter is made. This plasmid DNA plus plasmid DNA containing a PAT selectable marker is precipitated onto 1.1 μm (average diameter) tungsten pellets using a CaCl[0154] ₂precipitation procedure as follows:
100 μl prepared tungsten particles in water [0155]
10 μl (1 μg) DNA in TrisEDTA buffer (1 μg total) [0156]
100 μl 2.5 M CaCl[0157] ₂
10 μl 0.1 M spermidine [0158]
Each reagent is added sequentially to the tungsten particle suspension, while maintained on the multitube vortexer. The final mixture is sonicated briefly and allowed to incubate under constant vortexing for 10 minutes. After the precipitation period, the tubes are centrifuged briefly, liquid removed, washed with 500 [0159] ml 100% ethanol, and centrifuged for 30 seconds. Again the liquid is removed, and 105 μl 100% ethanol is added to the final tungsten particle pellet. For particle gun bombardment, the tungsten/DNA particles are briefly sonicated and 10 μl spotted onto the center of each macrocarrier and allowed to dry about 2 minutes before bombardment.
Particle Gun Treatment [0160]
The sample plates are bombarded at level #4 in particle gun #HE34-1 or #HE34-2. All samples receive a single shot at 650 PSI, with a total of ten aliquots taken from each tube of prepared particles/DNA. [0161]
Subsequent Treatment [0162]
Following bombardment, the embryos are kept on 560Y medium for 2 days, then transferred to 560R selection medium containing 3 mg/liter Bialaphos, and subcultured every 2 weeks. After approximately 10 weeks of selection, selection-resistant callus clones are transferred to 288J medium to initiate plant regeneration. Following somatic embryo maturation (2-4 weeks), well-developed somatic embryos are transferred to medium for germination and transferred to the lighted culture room. Approximately 7-10 days later, developing plantlets are transferred to 272V hormone-free medium in tubes for 7-10 days until plantlets are well established. Plants are then transferred to inserts in flats (equivalent to 2.5″ pot) containing potting soil and grown for 1 week in a growth chamber, subsequently grown an additional 1-2 weeks in the greenhouse, then transferred to classic 600 pots (1.6 gallon) and grown to maturity. Plants are monitored and scored for expression of the RPA gene of interest. [0163]
All publications and patent applications mentioned in the specification are indicative of the level of those skilled in the art to which this invention pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. [0164]
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims. [0165]
1 22 1 2497 DNA Zea Mays CDS (157)...(2025) Coding sequence for the Maize RPA Large Subunit Homologue-1 1 ccttatcata ttataagcgc gcgtagcctt ggcagctcga cgcatcttcg cctccgctca 60 acgctcgccc acgcccccag cccccaccga tccacgagaa accttctcgc ctccgcggga 120 cgattcgcca gggagagcaa aggtagcaga ggcgcc atg gac gct gcc aag tcg 174 Met Asp Ala Ala Lys Ser 1 5 gtg acg ccg ggc gcc gtg tcc tac atc ctg gcg cac ccg tct acg ggc 222 Val Thr Pro Gly Ala Val Ser Tyr Ile Leu Ala His Pro Ser Thr Gly 10 15 20 tcc gat ggc gcc gtg tcg gat ctc gtc gtt cag gtc ctc gat ctc aag 270 Ser Asp Gly Ala Val Ser Asp Leu Val Val Gln Val Leu Asp Leu Lys 25 30 35 tcc atc ggc atg ggc agc cgg ttc agt ttc acg gca tcc gat ggg aac 318 Ser Ile Gly Met Gly Ser Arg Phe Ser Phe Thr Ala Ser Asp Gly Asn 40 45 50 gac aaa atc aag gcg atg ctc ccc act tac ttt gcg tcg gag gtc cac 366 Asp Lys Ile Lys Ala Met Leu Pro Thr Tyr Phe Ala Ser Glu Val His 55 60 65 70 tcc ggc aat ctg aag aat ttc ggt ctc atc cgc atc ctc gac tac act 414 Ser Gly Asn Leu Lys Asn Phe Gly Leu Ile Arg Ile Leu Asp Tyr Thr 75 80 85 tgc aac tcc gtc aaa ggc aac gct gac aaa gtc ctg att gtc gtc aaa 462 Cys Asn Ser Val Lys Gly Asn Ala Asp Lys Val Leu Ile Val Val Lys 90 95 100 tgc gag act gtg tgc gaa gcg ctc gac gcc gag atc aac ggc gag gcc 510 Cys Glu Thr Val Cys Glu Ala Leu Asp Ala Glu Ile Asn Gly Glu Ala 105 110 115 aag aaa gag gat cct cca att gtg ctg aag cct aaa gac gaa ggc tca 558 Lys Lys Glu Asp Pro Pro Ile Val Leu Lys Pro Lys Asp Glu Gly Ser 120 125 130 gtc gtg gct gag gaa aca aat tct ccc cca ctc gtg atg aag cct aag 606 Val Val Ala Glu Glu Thr Asn Ser Pro Pro Leu Val Met Lys Pro Lys 135 140 145 150 caa gag gtg aag tcc gcg tcc cag atc gtg act gag cag cgt gga aat 654 Gln Glu Val Lys Ser Ala Ser Gln Ile Val Thr Glu Gln Arg Gly Asn 155 160 165 gct gct cct gcc acg cgc ctt tcc atg aca agg agg gtc cat ccc ttg 702 Ala Ala Pro Ala Thr Arg Leu Ser Met Thr Arg Arg Val His Pro Leu 170 175 180 atc act ctg aac ccc tac cag ggt aac tgg gtc att aag gtg cgg gtc 750 Ile Thr Leu Asn Pro Tyr Gln Gly Asn Trp Val Ile Lys Val Arg Val 185 190 195 acg agc aaa ggc aat ctg aga acc tac agg aat gct cgt gga gaa ggc 798 Thr Ser Lys Gly Asn Leu Arg Thr Tyr Arg Asn Ala Arg Gly Glu Gly 200 205 210 tgc gtc ttc aac gta gag ctt act gat gag gat ggc acc cag atc cag 846 Cys Val Phe Asn Val Glu Leu Thr Asp Glu Asp Gly Thr Gln Ile Gln 215 220 225 230 gcc acc atg ttt aac gag gct gca aag aag ttc tat cca att ttt gag 894 Ala Thr Met Phe Asn Glu Ala Ala Lys Lys Phe Tyr Pro Ile Phe Glu 235 240 245 ctg gga aag gtc tat tat gtc tca aaa gga tct ctt aga att gcc aac 942 Leu Gly Lys Val Tyr Tyr Val Ser Lys Gly Ser Leu Arg Ile Ala Asn 250 255 260 aag cag ttc aag aca gtc aaa aat gac tat gag ttg tca cta aac gag 990 Lys Gln Phe Lys Thr Val Lys Asn Asp Tyr Glu Leu Ser Leu Asn Glu 265 270 275 aat gct att gtt gaa gaa gca gag ggg gag act ttc ctt cca cca gtg 1038 Asn Ala Ile Val Glu Glu Ala Glu Gly Glu Thr Phe Leu Pro Pro Val 280 285 290 caa tac aac ctt gtc aag att gat cag cta gga cca tac gtc ggt ggc 1086 Gln Tyr Asn Leu Val Lys Ile Asp Gln Leu Gly Pro Tyr Val Gly Gly 295 300 305 310 agg gag ctt gta gat att gtt ggt gtg gtt cag agc gta tct ccc aca 1134 Arg Glu Leu Val Asp Ile Val Gly Val Val Gln Ser Val Ser Pro Thr 315 320 325 ctc agt gtt agg aga aag att gac aac gag aca ata ccg aag cgt gac 1182 Leu Ser Val Arg Arg Lys Ile Asp Asn Glu Thr Ile Pro Lys Arg Asp 330 335 340 att gtt gta gca gac gac tct ggc aaa act gtt act att tct ctc tgg 1230 Ile Val Val Ala Asp Asp Ser Gly Lys Thr Val Thr Ile Ser Leu Trp 345 350 355 aat gat ctt gct act acg act ggc caa gag ctt ttg gac atg gtt gac 1278 Asn Asp Leu Ala Thr Thr Thr Gly Gln Glu Leu Leu Asp Met Val Asp 360 365 370 agt tcg cct gtt gtt gcg ata aag agc cta aaa gta tct gac ttc caa 1326 Ser Ser Pro Val Val Ala Ile Lys Ser Leu Lys Val Ser Asp Phe Gln 375 380 385 390 ggc gtg tct ctt tca act att ggc aga agt act ctc gag att aat cct 1374 Gly Val Ser Leu Ser Thr Ile Gly Arg Ser Thr Leu Glu Ile Asn Pro 395 400 405 gac ctg cct gag gct aag aat ctt aag tcc tgg tat gac tct gaa ggc 1422 Asp Leu Pro Glu Ala Lys Asn Leu Lys Ser Trp Tyr Asp Ser Glu Gly 410 415 420 aaa gat act tca ctg gca cca atc agt gca gaa gcg ggt gcc aca cgc 1470 Lys Asp Thr Ser Leu Ala Pro Ile Ser Ala Glu Ala Gly Ala Thr Arg 425 430 435 gct ggt ggt ttc aag tcc atg tat tct gat aga gtt ttt ctg tct cac 1518 Ala Gly Gly Phe Lys Ser Met Tyr Ser Asp Arg Val Phe Leu Ser His 440 445 450 atc acc agt gat cct gct atg ggc cag gaa aag cct gtt ttc ttc agt 1566 Ile Thr Ser Asp Pro Ala Met Gly Gln Glu Lys Pro Val Phe Phe Ser 455 460 465 470 ctg tac gcc atc ata agc cac atc aag cct gat cag aat atg tgg tac 1614 Leu Tyr Ala Ile Ile Ser His Ile Lys Pro Asp Gln Asn Met Trp Tyr 475 480 485 cgt gct tgc acg acc tgt aac aag aag gtg act gaa gct ttt ggg tct 1662 Arg Ala Cys Thr Thr Cys Asn Lys Lys Val Thr Glu Ala Phe Gly Ser 490 495 500 gga tac tgg tgc gag ggg tgc caa aag aat gac tct gag tgc tcg ctg 1710 Gly Tyr Trp Cys Glu Gly Cys Gln Lys Asn Asp Ser Glu Cys Ser Leu 505 510 515 agg tac atc atg gtg atc aag ctc tcc gat ccc act ggt gag gct tgg 1758 Arg Tyr Ile Met Val Ile Lys Leu Ser Asp Pro Thr Gly Glu Ala Trp 520 525 530 gtg tcc gtg ttc aac gag cat gcg gag aag atc att ggc tgc agc gcc 1806 Val Ser Val Phe Asn Glu His Ala Glu Lys Ile Ile Gly Cys Ser Ala 535 540 545 550 gac gag ctt gat cgg atc agg aaa gag gag ggg gac gac agc tac gtt 1854 Asp Glu Leu Asp Arg Ile Arg Lys Glu Glu Gly Asp Asp Ser Tyr Val 555 560 565 ctc aag ctc aag gaa gcc acc tgg gtt cct cac ctg ttc cgc gtc agc 1902 Leu Lys Leu Lys Glu Ala Thr Trp Val Pro His Leu Phe Arg Val Ser 570 575 580 gtc aca cag cat gaa tac atg aac gag aag agg cag aga atc acc gtg 1950 Val Thr Gln His Glu Tyr Met Asn Glu Lys Arg Gln Arg Ile Thr Val 585 590 595 agg ggt gaa gca ccg gtc gac ttc gca gct gag tcc aag tac ttg ctt 1998 Arg Gly Glu Ala Pro Val Asp Phe Ala Ala Glu Ser Lys Tyr Leu Leu 600 605 610 gaa gag atc gcg aag ctc acc gct tgc tagaagacgc agtctttctg 2045 Glu Glu Ile Ala Lys Leu Thr Ala Cys 615 620 gtggttcttg aaggactggc ccccgatatg tctccctctc agtttttctt ttgagctcca 2105 gtaacttgat tactgttctg tgtgttgctc tcactgggtt ttagcacttc tgtaaggtat 2165 atgtagatgc tagtttacct tggtgtcaag gaacagatgc tattataagc cttgcaaaat 2225 tgcagttcca attccgtgta tctgcaacct tgagcaaata gggaaagatt atgagtacta 2285 attgatgatg ttaggtcgct gcagctaaca agtgtttggt ttttagtgac tactgtttag 2345 tccctatatt ttattctatt ttagtattta aggttgcgtt tggttgcgtc gactagacat 2405 gttgtgcgtg tccgatgagt ctattattga agcacaaaat tgggaataaa aaaaaaaaaa 2465 aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aa 2497 2 623 PRT Zea Mays 2 Met Asp Ala Ala Lys Ser Val Thr Pro Gly Ala Val Ser Tyr Ile Leu 1 5 10 15 Ala His Pro Ser Thr Gly Ser Asp Gly Ala Val Ser Asp Leu Val Val 20 25 30 Gln Val Leu Asp Leu Lys Ser Ile Gly Met Gly Ser Arg Phe Ser Phe 35 40 45 Thr Ala Ser Asp Gly Asn Asp Lys Ile Lys Ala Met Leu Pro Thr Tyr 50 55 60 Phe Ala Ser Glu Val His Ser Gly Asn Leu Lys Asn Phe Gly Leu Ile 65 70 75 80 Arg Ile Leu Asp Tyr Thr Cys Asn Ser Val Lys Gly Asn Ala Asp Lys 85 90 95 Val Leu Ile Val Val Lys Cys Glu Thr Val Cys Glu Ala Leu Asp Ala 100 105 110 Glu Ile Asn Gly Glu Ala Lys Lys Glu Asp Pro Pro Ile Val Leu Lys 115 120 125 Pro Lys Asp Glu Gly Ser Val Val Ala Glu Glu Thr Asn Ser Pro Pro 130 135 140 Leu Val Met Lys Pro Lys Gln Glu Val Lys Ser Ala Ser Gln Ile Val 145 150 155 160 Thr Glu Gln Arg Gly Asn Ala Ala Pro Ala Thr Arg Leu Ser Met Thr 165 170 175 Arg Arg Val His Pro Leu Ile Thr Leu Asn Pro Tyr Gln Gly Asn Trp 180 185 190 Val Ile Lys Val Arg Val Thr Ser Lys Gly Asn Leu Arg Thr Tyr Arg 195 200 205 Asn Ala Arg Gly Glu Gly Cys Val Phe Asn Val Glu Leu Thr Asp Glu 210 215 220 Asp Gly Thr Gln Ile Gln Ala Thr Met Phe Asn Glu Ala Ala Lys Lys 225 230 235 240 Phe Tyr Pro Ile Phe Glu Leu Gly Lys Val Tyr Tyr Val Ser Lys Gly 245 250 255 Ser Leu Arg Ile Ala Asn Lys Gln Phe Lys Thr Val Lys Asn Asp Tyr 260 265 270 Glu Leu Ser Leu Asn Glu Asn Ala Ile Val Glu Glu Ala Glu Gly Glu 275 280 285 Thr Phe Leu Pro Pro Val Gln Tyr Asn Leu Val Lys Ile Asp Gln Leu 290 295 300 Gly Pro Tyr Val Gly Gly Arg Glu Leu Val Asp Ile Val Gly Val Val 305 310 315 320 Gln Ser Val Ser Pro Thr Leu Ser Val Arg Arg Lys Ile Asp Asn Glu 325 330 335 Thr Ile Pro Lys Arg Asp Ile Val Val Ala Asp Asp Ser Gly Lys Thr 340 345 350 Val Thr Ile Ser Leu Trp Asn Asp Leu Ala Thr Thr Thr Gly Gln Glu 355 360 365 Leu Leu Asp Met Val Asp Ser Ser Pro Val Val Ala Ile Lys Ser Leu 370 375 380 Lys Val Ser Asp Phe Gln Gly Val Ser Leu Ser Thr Ile Gly Arg Ser 385 390 395 400 Thr Leu Glu Ile Asn Pro Asp Leu Pro Glu Ala Lys Asn Leu Lys Ser 405 410 415 Trp Tyr Asp Ser Glu Gly Lys Asp Thr Ser Leu Ala Pro Ile Ser Ala 420 425 430 Glu Ala Gly Ala Thr Arg Ala Gly Gly Phe Lys Ser Met Tyr Ser Asp 435 440 445 Arg Val Phe Leu Ser His Ile Thr Ser Asp Pro Ala Met Gly Gln Glu 450 455 460 Lys Pro Val Phe Phe Ser Leu Tyr Ala Ile Ile Ser His Ile Lys Pro 465 470 475 480 Asp Gln Asn Met Trp Tyr Arg Ala Cys Thr Thr Cys Asn Lys Lys Val 485 490 495 Thr Glu Ala Phe Gly Ser Gly Tyr Trp Cys Glu Gly Cys Gln Lys Asn 500 505 510 Asp Ser Glu Cys Ser Leu Arg Tyr Ile Met Val Ile Lys Leu Ser Asp 515 520 525 Pro Thr Gly Glu Ala Trp Val Ser Val Phe Asn Glu His Ala Glu Lys 530 535 540 Ile Ile Gly Cys Ser Ala Asp Glu Leu Asp Arg Ile Arg Lys Glu Glu 545 550 555 560 Gly Asp Asp Ser Tyr Val Leu Lys Leu Lys Glu Ala Thr Trp Val Pro 565 570 575 His Leu Phe Arg Val Ser Val Thr Gln His Glu Tyr Met Asn Glu Lys 580 585 590 Arg Gln Arg Ile Thr Val Arg Gly Glu Ala Pro Val Asp Phe Ala Ala 595 600 605 Glu Ser Lys Tyr Leu Leu Glu Glu Ile Ala Lys Leu Thr Ala Cys 610 615 620 3 2202 DNA Zea Mays CDS (91)...(1941) Coding Region for Maize RPA Large Subunit Homologue-2 3 acgttccccc cacgccccaa cctatccacg cgaaaccttc tttcccccgg gagacgattc 60 gtcagggaga ggaaagaggc aagaggggcc atg gac gct gcc aag ttg gtg acg 114 Met Asp Ala Ala Lys Leu Val Thr 1 5 ccg gtc gct gtg tct cac att ctg gcg cac ccg tcg gcg ggc tcc gac 162 Pro Val Ala Val Ser His Ile Leu Ala His Pro Ser Ala Gly Ser Asp 10 15 20 ggc gca gtg acc gat ctc gtc gtt cag gtc ctc gac ctg aag tcc gtc 210 Gly Ala Val Thr Asp Leu Val Val Gln Val Leu Asp Leu Lys Ser Val 25 30 35 40 ggc acg ggc agc cgg ttc agt ttc aca gca act gac ggg aag gat aag 258 Gly Thr Gly Ser Arg Phe Ser Phe Thr Ala Thr Asp Gly Lys Asp Lys 45 50 55 atc aag gcg atg ctt ccc acc aac ttc ggg tcg gag gtc cgc tct ggc 306 Ile Lys Ala Met Leu Pro Thr Asn Phe Gly Ser Glu Val Arg Ser Gly 60 65 70 aac ctg aag aac ctc ggc ctc atc cgc atc atc gac tac act tgc aac 354 Asn Leu Lys Asn Leu Gly Leu Ile Arg Ile Ile Asp Tyr Thr Cys Asn 75 80 85 gtc gtc aaa ggc aaa gat gac aaa gtc ttg gtt gtc atc aaa tgc gag 402 Val Val Lys Gly Lys Asp Asp Lys Val Leu Val Val Ile Lys Cys Glu 90 95 100 ctt gtg tgc caa gcg ctt gac gcc gag atc aac ggc gag gcc aaa aaa 450 Leu Val Cys Gln Ala Leu Asp Ala Glu Ile Asn Gly Glu Ala Lys Lys 105 110 115 120 gag gag cct cca att gtg ctg aag cct aag gac gaa tgc gtg ggc gtg 498 Glu Glu Pro Pro Ile Val Leu Lys Pro Lys Asp Glu Cys Val Gly Val 125 130 135 act tcc cca ctc gct atg aag ccc aag cag gag gtg aag tct gcg tcc 546 Thr Ser Pro Leu Ala Met Lys Pro Lys Gln Glu Val Lys Ser Ala Ser 140 145 150 cag atc gtg aat gag cag cgt gga aat act gct cct gtc aag ccc ctt 594 Gln Ile Val Asn Glu Gln Arg Gly Asn Thr Ala Pro Val Lys Pro Leu 155 160 165 tcc atg aca aag agg gtc cat cct ttg atc act ctg aac ccc tac cag 642 Ser Met Thr Lys Arg Val His Pro Leu Ile Thr Leu Asn Pro Tyr Gln 170 175 180 ggt aac tgg gtc att aag gtg cgg gtc acg agc aaa ggc aac ctg aga 690 Gly Asn Trp Val Ile Lys Val Arg Val Thr Ser Lys Gly Asn Leu Arg 185 190 195 200 acc tac agg aat gct cgc gga gaa ggc tgt gtc ttc aat gta gag ctc 738 Thr Tyr Arg Asn Ala Arg Gly Glu Gly Cys Val Phe Asn Val Glu Leu 205 210 215 acc gat gag gat ggc acc cag atc caa gcc acc atg ttt aat gac gct 786 Thr Asp Glu Asp Gly Thr Gln Ile Gln Ala Thr Met Phe Asn Asp Ala 220 225 230 gca aag aag ttc tat ccg att ttt gag ctg gga aag gtc tat tat gtc 834 Ala Lys Lys Phe Tyr Pro Ile Phe Glu Leu Gly Lys Val Tyr Tyr Val 235 240 245 tca aaa gga tct ctt aga att gct aac aag cag ttc aag act gtc caa 882 Ser Lys Gly Ser Leu Arg Ile Ala Asn Lys Gln Phe Lys Thr Val Gln 250 255 260 aat gac tac gag atg tca cta aac gag aat gct att gtt gaa gaa gca 930 Asn Asp Tyr Glu Met Ser Leu Asn Glu Asn Ala Ile Val Glu Glu Ala 265 270 275 280 gag ggg gag act tgc att ccg caa gtg caa tac aac ctt gtc aag att 978 Glu Gly Glu Thr Cys Ile Pro Gln Val Gln Tyr Asn Leu Val Lys Ile 285 290 295 gat caa cta gga tca tat gtc ggt ggc agg gaa ctt gta gat att gtt 1026 Asp Gln Leu Gly Ser Tyr Val Gly Gly Arg Glu Leu Val Asp Ile Val 300 305 310 ggt gtg gtt cag agc gta tct ccc aca ctc agt gtc agg aga aag att 1074 Gly Val Val Gln Ser Val Ser Pro Thr Leu Ser Val Arg Arg Lys Ile 315 320 325 gac aac gag aca ata ccg aag cgt gac att gtt gtg gcg gat gac tct 1122 Asp Asn Glu Thr Ile Pro Lys Arg Asp Ile Val Val Ala Asp Asp Ser 330 335 340 ggc aaa act gtt agt atc tct ctt tgg aat gat ctt gct act acg act 1170 Gly Lys Thr Val Ser Ile Ser Leu Trp Asn Asp Leu Ala Thr Thr Thr 345 350 355 360 ggg caa gag ctt ttg gac atg gct gac agt tcg cct gtt gtt gcg ata 1218 Gly Gln Glu Leu Leu Asp Met Ala Asp Ser Ser Pro Val Val Ala Ile 365 370 375 aag agc cta aaa gtg tct gac ttt caa ggc gtg tct ctt tct act gta 1266 Lys Ser Leu Lys Val Ser Asp Phe Gln Gly Val Ser Leu Ser Thr Val 380 385 390 ggc aaa agt act ctt gcg att aat cct gat cta cac gag gct cag aat 1314 Gly Lys Ser Thr Leu Ala Ile Asn Pro Asp Leu His Glu Ala Gln Asn 395 400 405 ctc aag tca tgg tat gac tct gaa ggc aaa gat act tcg ctg gca cca 1362 Leu Lys Ser Trp Tyr Asp Ser Glu Gly Lys Asp Thr Ser Leu Ala Pro 410 415 420 att ggt gca gaa atg ggt gcc gca cgg gcc ggt ggc ttc aag tcc acg 1410 Ile Gly Ala Glu Met Gly Ala Ala Arg Ala Gly Gly Phe Lys Ser Thr 425 430 435 440 tat tct gat aga gtt ttt ctg tct cac att act agt gat cct gcc atg 1458 Tyr Ser Asp Arg Val Phe Leu Ser His Ile Thr Ser Asp Pro Ala Met 445 450 455 ggc cag gaa aag cct gtt ttc ttc agt ttg tat gcc acc ata agc cac 1506 Gly Gln Glu Lys Pro Val Phe Phe Ser Leu Tyr Ala Thr Ile Ser His 460 465 470 atc aag cct gac cag aac atg tgg tac cgt gct tgc aag acc tgc aac 1554 Ile Lys Pro Asp Gln Asn Met Trp Tyr Arg Ala Cys Lys Thr Cys Asn 475 480 485 aag aag gtg act gaa act ttt gga tct gga tac tgg tgc gag gga tgc 1602 Lys Lys Val Thr Glu Thr Phe Gly Ser Gly Tyr Trp Cys Glu Gly Cys 490 495 500 caa aag aat gac tcg gaa tgc tca ctg aga tac atc atg gtc atc aag 1650 Gln Lys Asn Asp Ser Glu Cys Ser Leu Arg Tyr Ile Met Val Ile Lys 505 510 515 520 gtc tcc gat cct act ggc gag gca tgg ttc tct gtg ttc aac gag cat 1698 Val Ser Asp Pro Thr Gly Glu Ala Trp Phe Ser Val Phe Asn Glu His 525 530 535 gca gag aag atc att ggc tgc agc gcc gac gag ctt gat cgg atc agg 1746 Ala Glu Lys Ile Ile Gly Cys Ser Ala Asp Glu Leu Asp Arg Ile Arg 540 545 550 aaa gag gag ggg gac gac agt tat gtt ctg aag ctc aag gaa gcc acc 1794 Lys Glu Glu Gly Asp Asp Ser Tyr Val Leu Lys Leu Lys Glu Ala Thr 555 560 565 tgg gtt cct cac ctg ttc cgc gtc agc gtc aca cag cat gaa tac aat 1842 Trp Val Pro His Leu Phe Arg Val Ser Val Thr Gln His Glu Tyr Asn 570 575 580 aac gag aaa agg cag aga atc act gtg agg agt gaa gcg ccg gtc gag 1890 Asn Glu Lys Arg Gln Arg Ile Thr Val Arg Ser Glu Ala Pro Val Glu 585 590 595 600 cac gca gct gaa tcc aag tac ctg ctt gaa cag ata gcg aag ctt act 1938 His Ala Ala Glu Ser Lys Tyr Leu Leu Glu Gln Ile Ala Lys Leu Thr 605 610 615 gct tgatagtaga agatgcaacc ttactgcaaa tagcgaggat tattaggact 1991 Ala aattgatggt gtcaggtcat tgcggcccta agctttagct ctctatcagc agtcagatgt 2051 attaaccatt ccctgctcta atagtcatct atcagcagtc agatgtattt aaccaaaaaa 2111 aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaagggcgg ccgctctaga 2171 ggatccaagc ttacgtacgc gtgcatgcga c 2202 4 617 PRT Zea Mays 4 Met Asp Ala Ala Lys Leu Val Thr Pro Val Ala Val Ser His Ile Leu 1 5 10 15 Ala His Pro Ser Ala Gly Ser Asp Gly Ala Val Thr Asp Leu Val Val 20 25 30 Gln Val Leu Asp Leu Lys Ser Val Gly Thr Gly Ser Arg Phe Ser Phe 35 40 45 Thr Ala Thr Asp Gly Lys Asp Lys Ile Lys Ala Met Leu Pro Thr Asn 50 55 60 Phe Gly Ser Glu Val Arg Ser Gly Asn Leu Lys Asn Leu Gly Leu Ile 65 70 75 80 Arg Ile Ile Asp Tyr Thr Cys Asn Val Val Lys Gly Lys Asp Asp Lys 85 90 95 Val Leu Val Val Ile Lys Cys Glu Leu Val Cys Gln Ala Leu Asp Ala 100 105 110 Glu Ile Asn Gly Glu Ala Lys Lys Glu Glu Pro Pro Ile Val Leu Lys 115 120 125 Pro Lys Asp Glu Cys Val Gly Val Thr Ser Pro Leu Ala Met Lys Pro 130 135 140 Lys Gln Glu Val Lys Ser Ala Ser Gln Ile Val Asn Glu Gln Arg Gly 145 150 155 160 Asn Thr Ala Pro Val Lys Pro Leu Ser Met Thr Lys Arg Val His Pro 165 170 175 Leu Ile Thr Leu Asn Pro Tyr Gln Gly Asn Trp Val Ile Lys Val Arg 180 185 190 Val Thr Ser Lys Gly Asn Leu Arg Thr Tyr Arg Asn Ala Arg Gly Glu 195 200 205 Gly Cys Val Phe Asn Val Glu Leu Thr Asp Glu Asp Gly Thr Gln Ile 210 215 220 Gln Ala Thr Met Phe Asn Asp Ala Ala Lys Lys Phe Tyr Pro Ile Phe 225 230 235 240 Glu Leu Gly Lys Val Tyr Tyr Val Ser Lys Gly Ser Leu Arg Ile Ala 245 250 255 Asn Lys Gln Phe Lys Thr Val Gln Asn Asp Tyr Glu Met Ser Leu Asn 260 265 270 Glu Asn Ala Ile Val Glu Glu Ala Glu Gly Glu Thr Cys Ile Pro Gln 275 280 285 Val Gln Tyr Asn Leu Val Lys Ile Asp Gln Leu Gly Ser Tyr Val Gly 290 295 300 Gly Arg Glu Leu Val Asp Ile Val Gly Val Val Gln Ser Val Ser Pro 305 310 315 320 Thr Leu Ser Val Arg Arg Lys Ile Asp Asn Glu Thr Ile Pro Lys Arg 325 330 335 Asp Ile Val Val Ala Asp Asp Ser Gly Lys Thr Val Ser Ile Ser Leu 340 345 350 Trp Asn Asp Leu Ala Thr Thr Thr Gly Gln Glu Leu Leu Asp Met Ala 355 360 365 Asp Ser Ser Pro Val Val Ala Ile Lys Ser Leu Lys Val Ser Asp Phe 370 375 380 Gln Gly Val Ser Leu Ser Thr Val Gly Lys Ser Thr Leu Ala Ile Asn 385 390 395 400 Pro Asp Leu His Glu Ala Gln Asn Leu Lys Ser Trp Tyr Asp Ser Glu 405 410 415 Gly Lys Asp Thr Ser Leu Ala Pro Ile Gly Ala Glu Met Gly Ala Ala 420 425 430 Arg Ala Gly Gly Phe Lys Ser Thr Tyr Ser Asp Arg Val Phe Leu Ser 435 440 445 His Ile Thr Ser Asp Pro Ala Met Gly Gln Glu Lys Pro Val Phe Phe 450 455 460 Ser Leu Tyr Ala Thr Ile Ser His Ile Lys Pro Asp Gln Asn Met Trp 465 470 475 480 Tyr Arg Ala Cys Lys Thr Cys Asn Lys Lys Val Thr Glu Thr Phe Gly 485 490 495 Ser Gly Tyr Trp Cys Glu Gly Cys Gln Lys Asn Asp Ser Glu Cys Ser 500 505 510 Leu Arg Tyr Ile Met Val Ile Lys Val Ser Asp Pro Thr Gly Glu Ala 515 520 525 Trp Phe Ser Val Phe Asn Glu His Ala Glu Lys Ile Ile Gly Cys Ser 530 535 540 Ala Asp Glu Leu Asp Arg Ile Arg Lys Glu Glu Gly Asp Asp Ser Tyr 545 550 555 560 Val Leu Lys Leu Lys Glu Ala Thr Trp Val Pro His Leu Phe Arg Val 565 570 575 Ser Val Thr Gln His Glu Tyr Asn Asn Glu Lys Arg Gln Arg Ile Thr 580 585 590 Val Arg Ser Glu Ala Pro Val Glu His Ala Ala Glu Ser Lys Tyr Leu 595 600 605 Leu Glu Gln Ile Ala Lys Leu Thr Ala 610 615 5 630 PRT Oryza sativa 5 Met Asp Ser Asp Ala Ala Pro Ser Val Thr Pro Gly Ala Val Ala Phe 1 5 10 15 Val Leu Glu Asn Ala Ser Pro Asp Ala Ala Thr Gly Val Pro Val Pro 20 25 30 Glu Ile Val Leu Gln Val Val Asp Leu Lys Pro Ile Gly Thr Arg Phe 35 40 45 Thr Phe Leu Ala Ser Asp Gly Lys Asp Lys Ile Lys Thr Met Leu Leu 50 55 60 Thr Gln Leu Ala Pro Glu Val Arg Ser Gly Asn Ile Gln Asn Leu Gly 65 70 75 80 Val Ile Arg Val Leu Asp Tyr Thr Cys Asn Thr Ile Gly Glu Lys Gln 85 90 95 Glu Lys Val Leu Ile Ile Thr Lys Leu Glu Val Val Phe Lys Ala Leu 100 105 110 Asp Ser Glu Ile Lys Cys Glu Ala Glu Lys Gln Glu Glu Lys Pro Ala 115 120 125 Ile Leu Leu Ser Pro Lys Glu Glu Ser Val Val Leu Ser Lys Pro Thr 130 135 140 Asn Ala Pro Pro Leu Pro Pro Val Val Leu Lys Pro Lys Gln Glu Val 145 150 155 160 Lys Ser Ala Ser Gln Ile Val Asn Glu Gln Arg Gly Asn Ala Ala Pro 165 170 175 Ala Ala Arg Leu Ala Met Thr Arg Arg Val His Pro Leu Ile Ser Leu 180 185 190 Asn Pro Tyr Gln Gly Asn Trp Ile Ile Lys Val Arg Val Thr Ser Lys 195 200 205 Gly Asn Leu Arg Thr Tyr Lys Asn Ala Arg Gly Glu Gly Cys Val Phe 210 215 220 Asn Val Glu Leu Thr Asp Val Asp Gly Thr Gln Ile Gln Ala Thr Met 225 230 235 240 Phe Asn Glu Ala Ala Lys Lys Phe Tyr Pro Met Phe Glu Leu Gly Lys 245 250 255 Val Tyr Tyr Ile Ser Lys Gly Ser Leu Arg Val Ala Asn Lys Gln Phe 260 265 270 Lys Thr Val His Asn Asp Tyr Glu Met Thr Leu Asn Glu Asn Ala Val 275 280 285 Val Glu Glu Ala Glu Gly Glu Thr Phe Ile Pro Gln Ile Gln Tyr Asn 290 295 300 Phe Val Lys Ile Asp Gln Leu Gly Pro Tyr Val Gly Gly Arg Glu Leu 305 310 315 320 Val Asp Val Ile Gly Val Val Gln Ser Val Ser Pro Thr Leu Ser Val 325 330 335 Arg Arg Lys Ile Asp Asn Glu Thr Ile Pro Lys Arg Asp Ile Val Val 340 345 350 Ala Asp Asp Ser Ser Lys Thr Val Thr Ile Ser Leu Trp Asn Asp Leu 355 360 365 Ala Thr Thr Thr Gly Gln Glu Leu Leu Asp Met Val Asp Ser Ala Pro 370 375 380 Ile Ile Ala Ile Lys Ser Leu Lys Val Ser Asp Phe Gln Gly Leu Ser 385 390 395 400 Leu Ser Thr Val Gly Arg Ser Thr Ile Val Val Asn Pro Asp Leu Pro 405 410 415 Glu Ala Glu Gln Leu Arg Ala Trp Tyr Asp Ser Glu Gly Lys Gly Thr 420 425 430 Ser Met Ala Ser Ile Gly Ser Asp Met Gly Ala Ser Arg Val Gly Gly 435 440 445 Ala Arg Ser Met Tyr Ser Asp Arg Val Phe Leu Ser His Ile Thr Ser 450 455 460 Asp Pro Asn Leu Gly Gln Asp Lys Pro Val Phe Phe Ser Leu Asn Ala 465 470 475 480 Tyr Ile Ser Leu Ile Lys Pro Asp Gln Thr Met Trp Tyr Arg Ala Cys 485 490 495 Lys Thr Cys Asn Lys Lys Val Thr Glu Ala Met Gly Ser Gly Tyr Trp 500 505 510 Cys Glu Gly Cys Gln Lys Asn Asp Ala Glu Cys Ser Leu Arg Tyr Ile 515 520 525 Met Val Ile Lys Val Ser Asp Pro Thr Gly Glu Ala Trp Leu Ser Leu 530 535 540 Phe Asn Asp Gln Ala Glu Arg Ile Val Gly Cys Ser Ala Asp Glu Leu 545 550 555 560 Asp Arg Ile Arg Lys Glu Glu Gly Asp Asp Ser Tyr Leu Leu Lys Leu 565 570 575 Lys Glu Ala Thr Trp Val Pro His Leu Phe Arg Val Ser Val Thr Gln 580 585 590 Asn Glu Tyr Met Asn Glu Lys Arg Gln Arg Ile Thr Val Arg Ser Glu 595 600 605 Ala Pro Val Asp His Ala Ala Glu Ala Lys Tyr Met Leu Glu Glu Ile 610 615 620 Ala Lys Leu Thr Gly Cys 625 630 6 609 PRT Xenopus laevis 6 Met Ala Leu Pro Gln Leu Ser Glu Gly Ala Ile Ser Ala Met Leu Gly 1 5 10 15 Gly Asp Ser Ser Cys Lys Pro Thr Leu Gln Val Ile Asn Ile Arg Pro 20 25 30 Ile Asn Thr Gly Asn Gly Pro Pro Arg Tyr Arg Leu Leu Met Ser Asp 35 40 45 Gly Leu Asn Thr Leu Ser Ser Phe Met Leu Ala Thr Gln Leu Asn Ser 50 55 60 Leu Val Asp Asn Asn Leu Leu Ala Thr Asn Cys Ile Cys Gln Val Ser 65 70 75 80 Arg Phe Ile Val Asn Asn Leu Lys Asp Gly Arg Arg Val Ile Ile Val 85 90 95 Met Glu Leu Asp Val Leu Lys Ser Ala Asp Leu Val Met Gly Lys Ile 100 105 110 Gly Asn Pro Gln Pro Tyr Asn Asp Gly Gln Pro Gln Pro Ala Ala Pro 115 120 125 Ala Pro Ala Ser Ala Pro Ala Pro Ala Pro Ser Lys Leu Gln Asn Asn 130 135 140 Ser Ala Pro Pro Pro Ser Met Asn Arg Gly Thr Ser Lys Leu Phe Gly 145 150 155 160 Gly Gly Ser Leu Leu Asn Thr Pro Gly Gly Ser Gln Ser Lys Val Val 165 170 175 Pro Ile Ala Ser Leu Asn Pro Tyr Gln Ser Lys Trp Thr Val Arg Ala 180 185 190 Arg Val Thr Asn Lys Gly Gln Ile Arg Thr Trp Ser Asn Ser Arg Gly 195 200 205 Glu Gly Lys Leu Phe Ser Ile Glu Met Val Asp Glu Ser Gly Glu Ile 210 215 220 Arg Ala Thr Ala Phe Asn Glu Gln Ala Asp Lys Phe Phe Ser Ile Ile 225 230 235 240 Glu Val Asn Lys Val Tyr Tyr Phe Ser Lys Gly Thr Leu Lys Ile Ala 245 250 255 Asn Lys Gln Tyr Thr Ser Val Lys Asn Asp Tyr Glu Met Thr Phe Asn 260 265 270 Ser Glu Thr Ser Val Ile Pro Cys Asp Asp Ser Ala Asp Val Pro Met 275 280 285 Val Gln Phe Glu Phe Val Ser Ile Gly Glu Leu Glu Ser Lys Asn Lys 290 295 300 Asp Thr Val Leu Asp Ile Ile Gly Val Cys Lys Asn Val Glu Glu Val 305 310 315 320 Thr Lys Val Thr Ile Lys Ser Asn Asn Arg Glu Val Ser Lys Arg Ser 325 330 335 Ile His Leu Met Asp Ser Ser Gly Lys Val Val Ser Thr Thr Leu Trp 340 345 350 Gly Glu Asp Ala Asp Lys Phe Asp Gly Ser Arg Gln Pro Val Val Ala 355 360 365 Ile Lys Gly Ala Arg Leu Ser Asp Phe Gly Gly Arg Ser Leu Ser Val 370 375 380 Leu Ser Ser Ser Thr Val Met Ile Asn Pro Asp Ile Pro Glu Ala Phe 385 390 395 400 Lys Leu Arg Ala Trp Phe Asp Ser Glu Gly Gln Val Val Glu Gly Thr 405 410 415 Ser Ile Ser Glu Ser Arg Gly Gly Gly Thr Gly Gly Gly Asn Thr Asn 420 425 430 Trp Lys Ser Leu Leu Glu Val Lys Asn Glu Asn Leu Gly His Gly Glu 435 440 445 Lys Ala Asp Tyr Phe Thr Ser Val Ala Thr Ile Val Tyr Leu Arg Lys 450 455 460 Glu Asn Cys Leu Tyr Gln Ala Cys Pro Ser Gln Asp Cys Asn Lys Lys 465 470 475 480 Val Ile Asp Gln Gln Asn Gly Leu Phe Arg Cys Glu Lys Cys Asn Lys 485 490 495 Glu Phe Pro Asn Phe Lys Tyr Arg Leu Ile Leu Ser Ala Asn Ile Ala 500 505 510 Asp Phe Gly Glu Asn Gln Trp Ile Thr Cys Phe Gln Glu Ser Ala Glu 515 520 525 Ser Ile Leu Gly Gln Asn Ala Thr Tyr Leu Gly Glu Leu Lys Glu Lys 530 535 540 Asn Glu Gln Ala Tyr Asp Glu Val Phe Gln Asn Ala Asn Phe Arg Ser 545 550 555 560 Tyr Thr Phe Arg Ala Arg Val Lys Leu Glu Thr Tyr Asn Asp Glu Ser 565 570 575 Arg Ile Lys Ala Thr Ala Val Asp Val Lys Pro Val Asp His Lys Glu 580 585 590 Tyr Ser Arg Arg Leu Ile Met Asn Ile Arg Lys Met Ala Thr Gln Gly 595 600 605 Val 7 616 PRT Homo sapiens 7 Met Val Gly Gln Leu Ser Glu Gly Ala Ile Ala Ala Ile Met Gln Lys 1 5 10 15 Gly Asp Thr Asn Ile Lys Pro Ile Leu Gln Val Ile Asn Ile Arg Pro 20 25 30 Ile Thr Thr Gly Asn Ser Pro Pro Arg Tyr Arg Leu Leu Met Ser Asp 35 40 45 Gly Leu Asn Thr Leu Ser Ser Phe Met Leu Ala Thr Gln Leu Asn Pro 50 55 60 Leu Val Glu Glu Glu Gln Leu Ser Ser Asn Cys Val Cys Gln Ile His 65 70 75 80 Arg Phe Ile Val Asn Thr Leu Lys Asp Gly Arg Arg Val Val Ile Leu 85 90 95 Met Glu Leu Glu Val Leu Lys Ser Ala Glu Ala Val Gly Val Lys Ile 100 105 110 Gly Asn Pro Val Pro Tyr Asn Glu Gly Leu Gly Gln Pro Gln Val Ala 115 120 125 Pro Pro Ala Pro Ala Ala Ser Pro Ala Ala Ser Ser Arg Pro Gln Pro 130 135 140 Gln Asn Gly Ser Ser Gly Met Gly Ser Thr Val Ser Lys Ala Tyr Gly 145 150 155 160 Ala Ser Lys Thr Phe Gly Lys Ala Ala Gly Pro Ser Leu Ser His Thr 165 170 175 Ser Gly Gly Thr Gln Ser Lys Val Val Pro Ile Ala Ser Leu Thr Pro 180 185 190 Tyr Gln Ser Lys Trp Thr Ile Cys Ala Arg Val Thr Asn Lys Ser Gln 195 200 205 Ile Arg Thr Trp Ser Asn Ser Arg Gly Glu Gly Lys Leu Phe Ser Leu 210 215 220 Glu Leu Val Asp Glu Ser Gly Glu Ile Arg Ala Thr Ala Phe Asn Glu 225 230 235 240 Gln Val Asp Lys Phe Phe Pro Leu Ile Glu Val Asn Lys Val Tyr Tyr 245 250 255 Phe Ser Lys Gly Thr Leu Lys Ile Ala Asn Lys Gln Phe Thr Ala Val 260 265 270 Lys Asn Asp Tyr Glu Met Thr Phe Asn Asn Glu Thr Ser Val Met Pro 275 280 285 Cys Glu Asp Asp His His Leu Pro Thr Val Gln Phe Asp Phe Thr Gly 290 295 300 Ile Asp Asp Leu Glu Asn Lys Ser Lys Asp Ser Leu Val Asp Ile Ile 305 310 315 320 Gly Ile Cys Lys Ser Tyr Glu Asp Ala Thr Lys Ile Thr Val Arg Ser 325 330 335 Asn Asn Arg Glu Val Ala Lys Arg Asn Ile Tyr Leu Met Asp Thr Ser 340 345 350 Gly Lys Val Val Thr Ala Thr Leu Trp Gly Glu Asp Ala Asp Lys Phe 355 360 365 Asp Gly Ser Arg Gln Pro Val Leu Ala Ile Lys Gly Ala Arg Val Ser 370 375 380 Asp Phe Gly Gly Arg Ser Leu Ser Val Leu Ser Ser Ser Thr Ile Ile 385 390 395 400 Ala Asn Pro Asp Ile Pro Glu Ala Tyr Lys Leu Arg Gly Trp Phe Asp 405 410 415 Ala Glu Gly Gln Ala Leu Asp Gly Val Ser Ile Ser Asp Leu Lys Ser 420 425 430 Gly Gly Val Gly Gly Ser Asn Thr Asn Trp Lys Thr Leu Tyr Glu Val 435 440 445 Lys Ser Glu Asn Leu Gly Gln Gly Asp Lys Pro Asp Tyr Phe Ser Ser 450 455 460 Val Ala Thr Val Val Tyr Leu Arg Lys Glu Asn Cys Met Tyr Gln Ala 465 470 475 480 Cys Pro Thr Gln Asp Cys Asn Lys Lys Val Ile Asp Gln Gln Asn Gly 485 490 495 Leu Tyr Arg Cys Glu Lys Cys Asp Thr Glu Phe Pro Asn Phe Lys Tyr 500 505 510 Arg Met Ile Leu Ser Val Asn Ile Ala Asp Phe Gln Glu Asn Gln Trp 515 520 525 Val Thr Cys Phe Gln Glu Ser Ala Glu Ala Ile Leu Gly Gln Asn Ala 530 535 540 Ala Tyr Leu Gly Glu Leu Lys Asp Lys Asn Glu Gln Ala Phe Glu Glu 545 550 555 560 Val Phe Gln Asn Ala Asn Phe Arg Ser Phe Ile Phe Arg Val Arg Val 565 570 575 Lys Val Glu Thr Tyr Asn Asp Glu Ser Arg Ile Lys Ala Thr Val Met 580 585 590 Asp Val Lys Pro Val Asp Tyr Arg Glu Tyr Gly Arg Arg Leu Val Met 595 600 605 Ser Ile Arg Arg Ser Ala Leu Met 610 615 8 603 PRT Drosophila melanogaster 8 Met Val Leu Ala Ser Leu Ser Thr Gly Val Ile Ala Arg Ile Met His 1 5 10 15 Gly Glu Val Val Asp Ala Pro Val Leu Gln Ile Leu Ala Ile Lys Lys 20 25 30 Ile Asn Ser Ala Ala Asp Ser Glu Arg Tyr Arg Ile Leu Ile Ser Asp 35 40 45 Gly Lys Tyr Phe Asn Ser Tyr Ala Met Leu Ala Ser Gln Leu Asn Val 50 55 60 Met Gln His Asn Gly Glu Leu Glu Glu Phe Thr Ile Val Gln Leu Asp 65 70 75 80 Lys Tyr Val Thr Ser Leu Val Gly Lys Asp Gly Ala Gly Lys Arg Val 85 90 95 Leu Ile Ile Ser Glu Leu Thr Val Val Asn Pro Gly Ala Glu Val Lys 100 105 110 Ser Lys Ile Gly Glu Pro Val Thr Tyr Glu Asn Ala Ala Lys Gln Asp 115 120 125 Leu Ala Pro Lys Pro Ala Val Thr Ser Asn Ser Lys Pro Ile Ala Lys 130 135 140 Lys Glu Pro Ser His Asn Asn Asn Asn Asn Ile Val Met Asn Ser Ser 145 150 155 160 Ile Asn Ser Gly Met Thr His Pro Ile Ser Ser Leu Ser Pro Tyr Gln 165 170 175 Asn Lys Trp Val Ile Lys Ala Arg Val Thr Ser Lys Ser Gly Ile Arg 180 185 190 Thr Trp Ser Asn Ala Arg Gly Glu Gly Lys Leu Phe Ser Met Asp Leu 195 200 205 Met Asp Glu Ser Gly Glu Ile Arg Ala Thr Ala Phe Lys Glu Gln Cys 210 215 220 Asp Lys Phe Tyr Asp Leu Ile Gln Val Asp Ser Val Tyr Tyr Ile Ser 225 230 235 240 Lys Cys Gln Leu Lys Pro Ala Asn Lys Gln Tyr Ser Ser Leu Asn Asn 245 250 255 Ala Tyr Glu Met Thr Phe Ser Gly Glu Thr Val Val Gln Leu Cys Glu 260 265 270 Asp Thr Asp Asp Asp Pro Ile Pro Glu Ile Lys Tyr Asn Leu Val Pro 275 280 285 Ile Ser Asp Val Ser Gly Met Glu Asn Lys Ala Ala Val Asp Thr Ile 290 295 300 Gly Ile Cys Lys Glu Val Gly Glu Leu Gln Ser Phe Val Ala Arg Thr 305 310 315 320 Thr Asn Lys Glu Phe Lys Lys Arg Asp Ile Thr Leu Val Asp Met Ser 325 330 335 Asn Ser Ala Ile Ser Leu Thr Leu Trp Gly Asp Asp Ala Val Asn Phe 340 345 350 Asp Gly His Val Gln Pro Val Ile Leu Val Lys Gly Thr Arg Ile Asn 355 360 365 Glu Phe Asn Gly Gly Lys Ser Leu Ser Leu Gly Gly Gly Ser Ile Met 370 375 380 Lys Ile Asn Pro Asp Ile Pro Glu Ala His Lys Leu Arg Gly Trp Phe 385 390 395 400 Asp Asn Gly Gly Gly Asp Ser Val Ala Asn Met Val Ser Ala Arg Thr 405 410 415 Gly Gly Gly Ser Phe Ser Thr Glu Trp Met Thr Leu Lys Asp Ala Arg 420 425 430 Ala Arg Asn Leu Gly Ser Gly Asp Lys Pro Asp Tyr Phe Gln Cys Lys 435 440 445 Ala Val Val His Ile Val Lys Gln Glu Asn Ala Phe Tyr Arg Ala Cys 450 455 460 Pro Gln Ser Asp Cys Asn Lys Lys Val Val Asp Glu Gly Asn Asp Gln 465 470 475 480 Phe Arg Cys Glu Lys Cys Asn Ala Leu Phe Pro Asn Phe Lys Tyr Arg 485 490 495 Leu Leu Ile Asn Met Ser Ile Gly Asp Trp Thr Ser Asn Arg Trp Val 500 505 510 Ser Ser Phe Asn Glu Val Gly Glu Gln Leu Leu Gly His Thr Ser Gln 515 520 525 Glu Val Gly Glu Ala Leu Glu Asn Asp Pro Ala Lys Ala Glu Gln Ile 530 535 540 Phe Ser Ala Leu Asn Phe Thr Ser His Ile Phe Lys Leu Arg Cys Lys 545 550 555 560 Asn Glu Val Tyr Gly Asp Met Thr Arg Asn Lys Leu Thr Val Gln Ser 565 570 575 Val Ala Pro Ile Asn His Lys Glu Tyr Asn Lys His Leu Leu Lys Glu 580 585 590 Leu Gln Glu Leu Thr Gly Ile Gly Ser Ser Asn 595 600 9 609 PRT Schizosaccharomyces pombe 9 Met Ala Glu Arg Leu Ser Val Gly Ala Leu Arg Ile Ile Asn Thr Ser 1 5 10 15 Asp Ala Ser Ser Phe Pro Pro Asn Pro Ile Leu Gln Val Leu Thr Val 20 25 30 Lys Glu Leu Asn Ser Asn Pro Thr Ser Gly Ala Pro Lys Arg Tyr Arg 35 40 45 Val Val Leu Ser Asp Ser Ile Asn Tyr Ala Gln Ser Met Leu Ser Thr 50 55 60 Gln Leu Asn His Leu Val Ala Glu Asn Lys Leu Gln Lys Gly Ala Phe 65 70 75 80 Val Gln Leu Thr Gln Phe Thr Val Asn Val Met Lys Glu Arg Lys Ile 85 90 95 Leu Ile Val Leu Gly Leu Asn Val Leu Thr Glu Leu Gly Val Met Asp 100 105 110 Lys Ile Gly Asn Pro Ala Gly Leu Glu Thr Val Asp Ala Leu Arg Gln 115 120 125 Gln Gln Asn Glu Gln Asn Asn Ala Ser Ala Pro Arg Thr Gly Ile Ser 130 135 140 Thr Ser Thr Asn Ser Phe Tyr Gly Asn Asn Ala Ala Ala Thr Ala Pro 145 150 155 160 Ala Pro Pro Pro Met Met Lys Lys Pro Ala Ala Pro Asn Ser Leu Ser 165 170 175 Thr Ile Ile Tyr Pro Ile Glu Gly Leu Ser Pro Tyr Gln Asn Lys Trp 180 185 190 Thr Ile Arg Ala Arg Val Thr Asn Lys Ser Glu Val Lys His Trp His 195 200 205 Asn Gln Arg Gly Glu Gly Lys Leu Phe Ser Val Asn Leu Leu Asp Glu 210 215 220 Ser Gly Glu Ile Arg Ala Thr Gly Phe Asn Asp Gln Val Asp Ala Phe 225 230 235 240 Tyr Asp Ile Leu Gln Glu Gly Ser Val Tyr Tyr Ile Ser Arg Cys Arg 245 250 255 Val Asn Ile Ala Lys Lys Gln Tyr Thr Asn Val Gln Asn Glu Tyr Glu 260 265 270 Leu Met Phe Glu Arg Asp Thr Glu Ile Arg Lys Ala Glu Asp Gln Thr 275 280 285 Ala Val Pro Val Ala Lys Phe Ser Phe Val Ser Leu Gln Glu Val Gly 290 295 300 Asp Val Ala Lys Asp Ala Val Ile Asp Val Ile Gly Val Leu Gln Asn 305 310 315 320 Val Gly Pro Val Gln Gln Ile Thr Ser Arg Ala Thr Ser Arg Gly Phe 325 330 335 Asp Lys Arg Asp Ile Thr Ile Val Asp Gln Thr Gly Tyr Glu Met Arg 340 345 350 Val Thr Leu Trp Gly Lys Thr Ala Ile Glu Phe Ser Val Ser Glu Glu 355 360 365 Ser Ile Leu Ala Phe Lys Gly Val Lys Val Asn Asp Phe Gln Gly Arg 370 375 380 Ser Leu Ser Met Leu Thr Ser Ser Thr Met Ser Val Asp Pro Asp Ile 385 390 395 400 Gln Glu Ser His Leu Leu Lys Gly Trp Tyr Asp Gly Gln Gly Arg Gly 405 410 415 Gln Glu Phe Ala Lys His Ser Val Ile Ser Ser Thr Leu Ser Thr Thr 420 425 430 Gly Arg Ser Ala Glu Arg Lys Asn Ile Ala Glu Val Gln Ala Glu His 435 440 445 Leu Gly Met Ser Glu Thr Pro Asp Tyr Phe Ser Leu Lys Gly Thr Ile 450 455 460 Val Tyr Ile Arg Lys Lys Asn Val Ser Tyr Pro Ala Cys Pro Ala Ala 465 470 475 480 Asp Cys Asn Lys Lys Val Phe Asp Gln Gly Gly Ser Trp Arg Cys Glu 485 490 495 Lys Cys Asn Lys Glu Tyr Asp Ala Pro Gln Tyr Arg Tyr Ile Ile Thr 500 505 510 Ile Ala Val Gly Asp His Thr Gly Gln Leu Trp Leu Asn Val Phe Asp 515 520 525 Asp Val Gly Lys Leu Ile Met His Lys Thr Ala Asp Glu Leu Asn Asp 530 535 540 Leu Gln Glu Asn Asp Glu Asn Ala Phe Met Asn Cys Met Ala Glu Ala 545 550 555 560 Cys Tyr Met Pro Tyr Ile Phe Gln Cys Arg Ala Lys Gln Asp Asn Phe 565 570 575 Lys Gly Glu Met Arg Val Arg Tyr Thr Val Met Ser Ile Asn Gln Met 580 585 590 Asp Trp Lys Glu Glu Ser Lys Arg Leu Ile Asn Phe Ile Glu Ser Ala 595 600 605 Gln 10 621 PRT Saccharomyces cerevisiae 10 Met Ser Ser Val Gln Leu Ser Arg Gly Asp Phe His Ser Ile Phe Thr 1 5 10 15 Asn Lys Gln Arg Tyr Asp Asn Pro Thr Gly Gly Val Tyr Gln Val Tyr 20 25 30 Asn Thr Arg Lys Ser Asp Gly Ala Asn Ser Asn Arg Lys Asn Leu Ile 35 40 45 Met Ile Ser Asp Gly Ile Tyr His Met Lys Ala Leu Leu Arg Asn Gln 50 55 60 Ala Ala Ser Lys Phe Gln Ser Met Glu Leu Gln Arg Gly Asp Ile Ile 65 70 75 80 Arg Val Ile Ile Ala Glu Pro Ala Ile Val Arg Glu Arg Lys Lys Tyr 85 90 95 Val Leu Leu Val Asp Asp Phe Glu Leu Val Gln Ser Arg Ala Asp Met 100 105 110 Val Asn Gln Thr Ser Thr Phe Leu Asp Asn Tyr Phe Ser Glu His Pro 115 120 125 Asn Glu Thr Leu Lys Asp Glu Asp Ile Thr Asp Ser Gly Asn Val Ala 130 135 140 Asn Gln Thr Asn Ala Ser Asn Ala Gly Val Pro Asp Met Leu His Ser 145 150 155 160 Asn Ser Asn Leu Asn Ala Asn Glu Arg Lys Phe Ala Asn Glu Asn Pro 165 170 175 Asn Ser Gln Lys Thr Arg Pro Ile Phe Ala Ile Glu Gln Leu Ser Pro 180 185 190 Tyr Gln Asn Val Trp Thr Ile Lys Ala Arg Val Ser Tyr Lys Gly Glu 195 200 205 Ile Lys Thr Trp His Asn Gln Arg Gly Asp Gly Lys Leu Phe Asn Val 210 215 220 Asn Phe Leu Asp Thr Ser Gly Glu Ile Arg Ala Thr Ala Phe Asn Asp 225 230 235 240 Phe Ala Thr Lys Phe Asn Glu Ile Leu Gln Glu Gly Lys Val Tyr Tyr 245 250 255 Val Ser Lys Ala Lys Leu Gln Pro Ala Lys Pro Gln Phe Thr Asn Leu 260 265 270 Thr His Pro Tyr Glu Leu Asn Leu Asp Arg Asp Thr Val Ile Glu Glu 275 280 285 Cys Phe Asp Glu Ser Asn Val Pro Lys Thr His Phe Asn Phe Ile Lys 290 295 300 Leu Asp Ala Ile Gln Asn Gln Glu Val Asn Ser Asn Val Asp Val Leu 305 310 315 320 Gly Ile Ile Gln Thr Ile Asn Pro His Phe Glu Leu Thr Ser Arg Ala 325 330 335 Gly Lys Lys Phe Asp Arg Arg Asp Ile Thr Ile Val Asp Asp Ser Gly 340 345 350 Phe Ser Ile Ser Val Gly Leu Trp Asn Gln Gln Ala Leu Asp Phe Asn 355 360 365 Leu Pro Glu Gly Ser Val Ala Ala Ile Lys Gly Val Arg Val Thr Asp 370 375 380 Phe Gly Gly Lys Ser Leu Ser Met Gly Phe Ser Ser Thr Leu Ile Pro 385 390 395 400 Asn Pro Glu Ile Pro Glu Ala Tyr Ala Leu Lys Gly Trp Tyr Asp Ser 405 410 415 Lys Gly Arg Asn Ala Asn Phe Ile Thr Leu Lys Gln Glu Pro Gly Met 420 425 430 Gly Gly Gln Ser Ala Ala Ser Leu Thr Lys Phe Ile Ala Gln Arg Ile 435 440 445 Thr Ile Ala Arg Ala Gln Ala Glu Asn Leu Gly Arg Ser Glu Lys Gly 450 455 460 Asp Phe Phe Ser Val Lys Ala Ala Ile Ser Phe Leu Lys Val Asp Asn 465 470 475 480 Phe Ala Tyr Pro Ala Cys Ser Asn Glu Asn Cys Asn Lys Lys Val Leu 485 490 495 Glu Gln Pro Asp Gly Thr Trp Arg Cys Glu Lys Cys Asp Thr Asn Asn 500 505 510 Ala Arg Pro Asn Trp Arg Tyr Ile Leu Thr Ile Ser Ile Ile Asp Glu 515 520 525 Thr Asn Gln Leu Trp Leu Thr Leu Phe Asp Asp Gln Ala Lys Gln Leu 530 535 540 Leu Gly Val Asp Ala Asn Thr Leu Met Ser Leu Lys Glu Glu Asp Pro 545 550 555 560 Asn Glu Phe Thr Lys Ile Thr Gln Ser Ile Gln Met Asn Glu Tyr Asp 565 570 575 Phe Arg Ile Arg Ala Arg Glu Asp Thr Tyr Asn Asp Gln Ser Arg Ile 580 585 590 Arg Tyr Thr Val Ala Asn Leu His Ser Leu Asn Tyr Arg Ala Glu Ala 595 600 605 Asp Tyr Leu Ala Asp Glu Leu Ser Lys Ala Leu Leu Ala 610 615 620 11 1124 DNA Zea mays misc_feature (0)...(0) Maize RPA Middle Subunit Homologue-1 11 tcgacccacg cgtccgatcc tcccatctgc gcacccgcaa gcctattcgc cgcacctcct 60 caggtgaccg ggaag atg atg ccg ttg agc caa acc gac ttc tcg ccg tcg 111 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser 1 5 10 cag ttc acc tcc tcc cag aat gcc gcc gcc gac tcc acc acg cct tcc 159 Gln Phe Thr Ser Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser 15 20 25 aag atg cgc ggc gcg tcc agc acc atg ccg ctc acc gtg aag cag gtc 207 Lys Met Arg Gly Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val 30 35 40 gtc gac gcg cag cag tct ggc acg ggc gag aag ggc gct ccg ttc atc 255 Val Asp Ala Gln Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile 45 50 55 60 gtc aat ggc gtc gag atg gct aac att cga ctt gtg ggg atg gtc aat 303 Val Asn Gly Val Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn 65 70 75 gcc aag gtg gag cgg acg acc gat gtg acc ttc acg ctc gac gat ggc 351 Ala Lys Val Glu Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly 80 85 90 acc ggc cgc ctc gat ttc atc aga tgg gtg aat gat gct tca gat tct 399 Thr Gly Arg Leu Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser 95 100 105 ttt gaa act gct gct att cag aat ggt atg tac att gcg gtc att gga 447 Phe Glu Thr Ala Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly 110 115 120 agc ctc aag gga ctg caa gag agg aag cgt gct act gct ttc tca atc 495 Ser Leu Lys Gly Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile 125 130 135 140 agg cct ata acc gat ttc aat gag gtt acg ctg cat ttc att cag tgt 543 Arg Pro Ile Thr Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys 145 150 155 gtt cgg atg cat ata gag aac att gaa tta aag gct ggc agt cct gca 591 Val Arg Met His Ile Glu Asn Ile Glu Leu Lys Ala Gly Ser Pro Ala 160 165 170 cga atc agt tct tct atg gga gtg tca ttc tca aat gga ttc agt gaa 639 Arg Ile Ser Ser Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu 175 180 185 tca agc aca ccg aca tct ttg aaa tcc agt ccc gca ccg gtg acc agc 687 Ser Ser Thr Pro Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser 190 195 200 ggg tca tcc gat act gat ctg cac acg cag gtc ctg aat ttt ttt aat 735 Gly Ser Ser Asp Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn 205 210 215 220 gaa cca gcg aac ctc gag agt gag cat ggg gtg cac gtt gat gaa gta 783 Glu Pro Ala Asn Leu Glu Ser Glu His Gly Val His Val Asp Glu Val 225 230 235 ctc aag cgg ttc aaa ctt ttg ccg aag aag cag atc acg gat gct att 831 Leu Lys Arg Phe Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile 240 245 250 gat tac aat atg gac tcg ggg cgt ctt tac tca aca att gat gaa ttc 879 Asp Tyr Asn Met Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe 255 260 265 cac tac aag gca act taaccgattt gaaggccagc ctgctggaaa tggcagagga 934 His Tyr Lys Ala Thr 270 ctaagtatca cttgtactaa accaaagtct ggaaatgtca tgttgtgtca tgaaatgcat 994 ggttggttta tggaaacatt tatatcttgt atcaactagt tgatttgtat ctcgtgtcaa 1054 cttaatgact gagccaagaa aaggaagatg tagaggccga cagaaaaaaa aaaaaaaaaa 1114 aaaaaaaaaa 1124 12 273 PRT Zea mays 12 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser 1 5 10 15 Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly 20 25 30 Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val Val Asp Ala Gln 35 40 45 Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile Val Asn Gly Val 50 55 60 Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu 65 70 75 80 Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu 85 90 95 Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala 100 105 110 Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly 115 120 125 Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr 130 135 140 Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His 145 150 155 160 Ile Glu Asn Ile Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Ser Ser 165 170 175 Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro 180 185 190 Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp 195 200 205 Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn 210 215 220 Leu Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe 225 230 235 240 Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met 245 250 255 Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe His Tyr Lys Ala 260 265 270 Thr 13 979 DNA Zea mays misc_feature (0)...(0) Maize RPA Middle Subunit Homologue-2 and 3 13 ttcggcacga gcgcacctcc tcaggtgacc gggaag atg atg ccg ttg agc caa 54 Met Met Pro Leu Ser Gln 1 5 acc gac ttc tcg ccg tcg cag ttc acc tcc tcc cag aat gcc gcc gcc 102 Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser Ser Gln Asn Ala Ala Ala 10 15 20 gac tcc acc acg cct tcc aag atg cgc ggc gcg tcc agc acc atg ccg 150 Asp Ser Thr Thr Pro Ser Lys Met Arg Gly Ala Ser Ser Thr Met Pro 25 30 35 ctc acc gtg aag cag gtc gtc gac gcg cag cag tct ggc acg ggc gac 198 Leu Thr Val Lys Gln Val Val Asp Ala Gln Gln Ser Gly Thr Gly Asp 40 45 50 aag ggc gct ccg ttc atc gtc aat ggc gtc gag atg gct aac att cga 246 Lys Gly Ala Pro Phe Ile Val Asn Gly Val Glu Met Ala Asn Ile Arg 55 60 65 70 ctt gtg ggg atg gtc aat gcc aag gtg gag cgg acg acc gat gtg acc 294 Leu Val Gly Met Val Asn Ala Lys Val Glu Arg Thr Thr Asp Val Thr 75 80 85 ttc acg ctc gac gat ggc acc ggc cgc ctc gat ttc atc aga tgg gtg 342 Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu Asp Phe Ile Arg Trp Val 90 95 100 aat gat gct tca gat tct ttt gaa act gct gct att cag aat ggt atg 390 Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala Ala Ile Gln Asn Gly Met 105 110 115 tac att gcg gtc att gga agc ctc aag gga ctg caa gag agg aag cgt 438 Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly Leu Gln Glu Arg Lys Arg 120 125 130 gct act gct ttc tca atc agg cct ata acc gat ttc aat gag gtt acg 486 Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr Asp Phe Asn Glu Val Thr 135 140 145 150 ctg cat ttc att cag tgt gtt cgg atg cat ata gag aac att gaa tta 534 Leu His Phe Ile Gln Cys Val Arg Met His Ile Glu Asn Ile Glu Leu 155 160 165 aag gct ggc agt cct gca cga atc agt tct tct atg gga gtg tca ttc 582 Lys Ala Gly Ser Pro Ala Arg Ile Ser Ser Ser Met Gly Val Ser Phe 170 175 180 tca aat gga ttc agt gaa tca agc aca ccg aca tct ttg aaa tcc agt 630 Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro Thr Ser Leu Lys Ser Ser 185 190 195 ccc gca ccg gtg acc agc ggg tca tcc gat act gat ctg cac acg cag 678 Pro Ala Pro Val Thr Ser Gly Ser Ser Asp Thr Asp Leu His Thr Gln 200 205 210 gtc ctg aat ttt ttt aat gaa cca gcg aac ctc gag agt gag cat ggg 726 Val Leu Asn Phe Phe Asn Glu Pro Ala Asn Leu Glu Ser Glu His Gly 215 220 225 230 gtg cac gtt gat gaa gta ctc aag cgg ttc aaa ctt ttg ccg aag aag 774 Val His Val Asp Glu Val Leu Lys Arg Phe Lys Leu Leu Pro Lys Lys 235 240 245 cag atc acg gat gct att gat tac aat atg gac tcg ggg cgt ctt tac 822 Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met Asp Ser Gly Arg Leu Tyr 250 255 260 tca aca att gat gaa ttc cac tac aag gca act taaccgattt gaaggccagc 875 Ser Thr Ile Asp Glu Phe His Tyr Lys Ala Thr 265 270 ctgctggaaa tggcagagga ctaagtatca cttgtactaa accaaagtct ggaaatgtca 935 tgttgtgtca tgaaatgcat ggttggttta tggaaacaaa aaaa 979 14 273 PRT Zea mays 14 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser 1 5 10 15 Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly 20 25 30 Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val Val Asp Ala Gln 35 40 45 Gln Ser Gly Thr Gly Asp Lys Gly Ala Pro Phe Ile Val Asn Gly Val 50 55 60 Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu 65 70 75 80 Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu 85 90 95 Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala 100 105 110 Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly 115 120 125 Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr 130 135 140 Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His 145 150 155 160 Ile Glu Asn Ile Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Ser Ser 165 170 175 Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro 180 185 190 Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp 195 200 205 Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn 210 215 220 Leu Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe 225 230 235 240 Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met 245 250 255 Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe His Tyr Lys Ala 260 265 270 Thr 15 1051 DNA Zea mays misc_feature (0)...(0) Maize RPA Middle Subunit Homologue-4 15 tcgacccacg cgtccgatcc tcccatctgc gcacccgcaa gcctattcgc cgcacctcct 60 caggtgaccg ggaag atg atg ccg ttg agc caa acc gac ttc tcg ccg tcg 111 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser 1 5 10 cag ttc acc tcc tcc cag aat gcc gcc gcc gac tcc acc acg cct tcc 159 Gln Phe Thr Ser Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser 15 20 25 aag atg cgc ggc gcg tcc agc acc atg ccg ctc acc gtg aag cag gtc 207 Lys Met Arg Gly Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val 30 35 40 gtc gac gcg cag cag tct ggc acg ggc gag aag ggc gct ccg ttc atc 255 Val Asp Ala Gln Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile 45 50 55 60 gtc aat ggc gtc gag atg gct aac att cga ctt gtg ggg atg gtc aat 303 Val Asn Gly Val Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn 65 70 75 gcc aag gtg gag cgg acg acc gat gtg acc ttc acg ctc gac gat ggc 351 Ala Lys Val Glu Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly 80 85 90 acc ggc cgc ctc gat ttc atc aga tgg gtg aat gat gct tca gat tct 399 Thr Gly Arg Leu Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser 95 100 105 ttt gaa act gct gct att cag aat ggt atg tac att gcg gtc att gga 447 Phe Glu Thr Ala Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly 110 115 120 agc ctc aag gga ctg caa gag agg aag cgt gct act gct ttc tca atc 495 Ser Leu Lys Gly Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile 125 130 135 140 agg cct ata acc gat ttc aat gag gtt acg ctg cat ttc att cag tgt 543 Arg Pro Ile Thr Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys 145 150 155 gtt cgg atg cat ata gag aac act gaa tta aag gct ggc agt cct gca 591 Val Arg Met His Ile Glu Asn Thr Glu Leu Lys Ala Gly Ser Pro Ala 160 165 170 cga atc aat tct tct atg gga gtg tca ttc tca aat gga ttc agt gaa 639 Arg Ile Asn Ser Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu 175 180 185 tca agc aca ccg aca tct ttg aaa tcc agt ccc gca ccg gtg acc agc 687 Ser Ser Thr Pro Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser 190 195 200 ggg tca tcc gat act gat ctg cac acg cag gtc ctg aat ttt ttt aat 735 Gly Ser Ser Asp Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn 205 210 215 220 gaa cca gcg aac ctc gag agt gag cat ggg gtg cac gtt gat gaa gta 783 Glu Pro Ala Asn Leu Glu Ser Glu His Gly Val His Val Asp Glu Val 225 230 235 ctc aag cgg ttc aaa ctt ttg ccg aag aag cag atc acg gat gct att 831 Leu Lys Arg Phe Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile 240 245 250 gat tac aat atg gac tcg ggg cgt ctt tac tca aca att gat gaa ttc 879 Asp Tyr Asn Met Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe 255 260 265 cac tac aag gca act taaccgattt gaaggtcagc ctgctggaaa tggcagagga 934 His Tyr Lys Ala Thr 270 ctaagtatca cttgtactaa accaaagtct ggaaatgtca tgttgtgtca tgaaatgcat 994 ggttggttta tggaaacaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaa 1051 16 273 PRT Zea mays 16 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser 1 5 10 15 Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly 20 25 30 Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val Val Asp Ala Gln 35 40 45 Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile Val Asn Gly Val 50 55 60 Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu 65 70 75 80 Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu 85 90 95 Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala 100 105 110 Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly 115 120 125 Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr 130 135 140 Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His 145 150 155 160 Ile Glu Asn Thr Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Asn Ser 165 170 175 Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro 180 185 190 Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp 195 200 205 Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn 210 215 220 Leu Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe 225 230 235 240 Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met 245 250 255 Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe His Tyr Lys Ala 260 265 270 Thr 17 1087 DNA Zea mays misc_feature (0)...(0) Maize RPA Middle Subunit Homologue-5 17 aattccgggg ccgacccacg cgtccgcatc gatcctccca tctgcgcacc cgcaagccta 60 ttcgccgcac ctcctcaggt gaccgggaag atg atg ccg ttg agc caa acc gac 114 Met Met Pro Leu Ser Gln Thr Asp 1 5 ttc tcg ccg tcg cag ttc acc tcc tcc cag aat gcc gcc gcc gac tcc 162 Phe Ser Pro Ser Gln Phe Thr Ser Ser Gln Asn Ala Ala Ala Asp Ser 10 15 20 acc acg cct tcc aag atg cgc ggc gcg tcc agc acc atg ccg ctc acc 210 Thr Thr Pro Ser Lys Met Arg Gly Ala Ser Ser Thr Met Pro Leu Thr 25 30 35 40 gtg aag car gtc gtc gac gcg cag cag tct ggc acg ggc gag aag ggc 258 Val Lys Xaa Val Val Asp Ala Gln Gln Ser Gly Thr Gly Glu Lys Gly 45 50 55 gct ccg ttc atc gtc aat ggc gtc gag atg gct aac att cga ctt gtg 306 Ala Pro Phe Ile Val Asn Gly Val Glu Met Ala Asn Ile Arg Leu Val 60 65 70 ggg atg gtc aat gcc aag gtg gag cgg acg acc gat gtg acc ttc acg 354 Gly Met Val Asn Ala Lys Val Glu Arg Thr Thr Asp Val Thr Phe Thr 75 80 85 ctc gac gat ggc acc ggc cgc ctc gat ttc atc aga tgg gtg aat gat 402 Leu Asp Asp Gly Thr Gly Arg Leu Asp Phe Ile Arg Trp Val Asn Asp 90 95 100 gct tca gat tct ttt gaa act gct gct att cag aat ggt atg tac att 450 Ala Ser Asp Ser Phe Glu Thr Ala Ala Ile Gln Asn Gly Met Tyr Ile 105 110 115 120 gcg gtc att gga agc ctc aag gga ctg caa gag agg aag cgt gct act 498 Ala Val Ile Gly Ser Leu Lys Gly Leu Gln Glu Arg Lys Arg Ala Thr 125 130 135 gct ttc tca atc agg cct ata acc gat ttc aat gag gtt acg ctg cat 546 Ala Phe Ser Ile Arg Pro Ile Thr Asp Phe Asn Glu Val Thr Leu His 140 145 150 ttc att cag tgt gtt cgg atg cat ata gag aac act gaa tta aag gct 594 Phe Ile Gln Cys Val Arg Met His Ile Glu Asn Thr Glu Leu Lys Ala 155 160 165 ggc agt cct gca cga atc aat tct tct atg gga gtg tca ttc tca aat 642 Gly Ser Pro Ala Arg Ile Asn Ser Ser Met Gly Val Ser Phe Ser Asn 170 175 180 gga ttc agt gaa tca agc aca ccg aca tct ttg aaa tcc agt ccc gca 690 Gly Phe Ser Glu Ser Ser Thr Pro Thr Ser Leu Lys Ser Ser Pro Ala 185 190 195 200 ccg gtg acc agc ggg tca tcc gat act gat ctg cac acg cag gtc ctg 738 Pro Val Thr Ser Gly Ser Ser Asp Thr Asp Leu His Thr Gln Val Leu 205 210 215 aat ttt ttt aat gaa cca gcg aac ctc gag agt gag cat ggg gtg cac 786 Asn Phe Phe Asn Glu Pro Ala Asn Leu Glu Ser Glu His Gly Val His 220 225 230 gtt gat gaa gta ctc aag cgg ttc aac ttt tgc cga aga agc aga tca 834 Val Asp Glu Val Leu Lys Arg Phe Asn Phe Cys Arg Arg Ser Arg Ser 235 240 245 cgg atg cta ttg att aca ata tgg act cgg ggc gtc ttt act caa caa 882 Arg Met Leu Leu Ile Thr Ile Trp Thr Arg Gly Val Phe Thr Gln Gln 250 255 260 ttg atg aat tcc act aca agg caa ctt aac cga ttt gaa ggt cag cct 930 Leu Met Asn Ser Thr Thr Arg Gln Leu Asn Arg Phe Glu Gly Gln Pro 265 270 275 280 gct gga aat ggc aga gga cta agt atc act tgt act aaa cca aag tct 978 Ala Gly Asn Gly Arg Gly Leu Ser Ile Thr Cys Thr Lys Pro Lys Ser 285 290 295 gga aat gtc atg ttg tgt cat gaa atg cat ggt tgg ttt atg gaa aca 1026 Gly Asn Val Met Leu Cys His Glu Met His Gly Trp Phe Met Glu Thr 300 305 310 ttt ata tct tgt atc aac tagttgattt gtatctcttg tgtcaaaaaa 1074 Phe Ile Ser Cys Ile Asn 315 aaaaaaaaaa aaa 1087 18 318 PRT Zea mays VARIANT (1)...(318) Xaa = Any Amino Acid 18 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser 1 5 10 15 Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly 20 25 30 Ala Ser Ser Thr Met Pro Leu Thr Val Lys Xaa Val Val Asp Ala Gln 35 40 45 Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile Val Asn Gly Val 50 55 60 Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu 65 70 75 80 Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu 85 90 95 Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala 100 105 110 Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly 115 120 125 Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr 130 135 140 Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His 145 150 155 160 Ile Glu Asn Thr Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Asn Ser 165 170 175 Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro 180 185 190 Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp 195 200 205 Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn 210 215 220 Leu Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe 225 230 235 240 Asn Phe Cys Arg Arg Ser Arg Ser Arg Met Leu Leu Ile Thr Ile Trp 245 250 255 Thr Arg Gly Val Phe Thr Gln Gln Leu Met Asn Ser Thr Thr Arg Gln 260 265 270 Leu Asn Arg Phe Glu Gly Gln Pro Ala Gly Asn Gly Arg Gly Leu Ser 275 280 285 Ile Thr Cys Thr Lys Pro Lys Ser Gly Asn Val Met Leu Cys His Glu 290 295 300 Met His Gly Trp Phe Met Glu Thr Phe Ile Ser Cys Ile Asn 305 310 315 19 1074 DNA Zea mays misc_feature (0)...(0) Maize RPA Middle Subunit Homologue-6 19 gacccacgcg tccgcgcaag cctattcgcc gcacctcctc aggtgaccgg gaag atg 57 Met 1 atg ccg ttg agc caa acc gac ttc tcg ccg tcg cag ttc acc tcc tcc 105 Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser Ser 5 10 15 cag aat gcc gcc gcc gac tcc acc acg cct tcc aag atg cgc ggc gcg 153 Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly Ala 20 25 30 tcc agc acc atg ccg ctc acc gtg aag cag gtc gtc gac gcg cag cag 201 Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val Val Asp Ala Gln Gln 35 40 45 tct ggc acg ggc gag aag ggc gct ccg ttc atc gtc aat ggc gtc gag 249 Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile Val Asn Gly Val Glu 50 55 60 65 atg gct aac att cga ctt gtg ggg atg gtc aat gcc aag gtg gag cgg 297 Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu Arg 70 75 80 acg acc gat gtg acc ttc acg ctc gac gat ggc acc ggc cgc ctc gat 345 Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu Asp 85 90 95 ttc atc aga tgg gtg aat gat gct tca gat tct ttt gaa act gct gct 393 Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala Ala 100 105 110 att cag aat ggt atg tac att gcg gtc att gga agc ctc aag gga ctg 441 Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly Leu 115 120 125 caa gag agg aag cgt gct act gct ttc tca atc agg cct ata acc gat 489 Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr Asp 130 135 140 145 ttc aat gag gtt acg ctg cat ttc att cag tgt gtt cgg atg cat ata 537 Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His Ile 150 155 160 gag aac act gaa tta aag gct ggc agt cct gca cga atc aat tct tct 585 Glu Asn Thr Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Asn Ser Ser 165 170 175 atg gga gtg tca ttc tca aat gga ttc agt gaa tca agc aca ccg aca 633 Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro Thr 180 185 190 tct ttg aaa tcc agt ccc gca ccg gtg acc agc ggg tca tcc gat act 681 Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp Thr 195 200 205 gat ctg cac acg cag gtc ctg aat ttt ttt aat gaa cca gcg aac ctc 729 Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn Leu 210 215 220 225 gag agt gag cat ggg gtg cac gtt gat gaa gta ctc aag cgg ttc aaa 777 Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe Lys 230 235 240 ctt ttg ccg aag aag cag atc acg gat gct att gat tac aat atg gac 825 Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met Asp 245 250 255 tcg ggg cgt ctt tac tca aca att gat gaa ttc cac tac aag gca act 873 Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe His Tyr Lys Ala Thr 260 265 270 taaccgattt gaaggtcagc ctgctggaaa tggcagagga ctaagtatca cttgtactaa 933 accaaagtct ggaaatgtca tgttgtgtca tgaaatgcat ggttggttta tggaaacatt 993 tatatcttgt atcaactagt tgatttgtat ctcttgtgtc aacttaatga ctgagccaac 1053 aaaaggaaaa aaaaaaaaaa a 1074 20 273 PRT Zea mays 20 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser 1 5 10 15 Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly 20 25 30 Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val Val Asp Ala Gln 35 40 45 Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile Val Asn Gly Val 50 55 60 Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu 65 70 75 80 Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu 85 90 95 Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala 100 105 110 Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly 115 120 125 Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr 130 135 140 Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His 145 150 155 160 Ile Glu Asn Thr Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Asn Ser 165 170 175 Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro 180 185 190 Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp 195 200 205 Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn 210 215 220 Leu Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe 225 230 235 240 Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met 245 250 255 Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe His Tyr Lys Ala 260 265 270 Thr 21 1231 DNA Zea mays misc_feature (0)...(0) Maize RPA Middle Subunit Homologue-7 21 tcccgggtcg acccacgcgt ccgcgatcct cccatctgcg cacccgcaag cctattcgcc 60 gcacctcctc aggtgaccgg gaag atg atg ccg ttg agc caa acc gac ttc 111 Met Met Pro Leu Ser Gln Thr Asp Phe 1 5 tcg ccg tcg cag ttc acc tcc tcc cag aat gcc gcc gcc gac tcc acc 159 Ser Pro Ser Gln Phe Thr Ser Ser Gln Asn Ala Ala Ala Asp Ser Thr 10 15 20 25 acg cct tcc aag atg cgc ggc gcg tcc agc acc atg ccg ctc acc gtg 207 Thr Pro Ser Lys Met Arg Gly Ala Ser Ser Thr Met Pro Leu Thr Val 30 35 40 aag cag gtc gtc gac gcg cag cag tct ggc acg ggc gag aag ggc gct 255 Lys Gln Val Val Asp Ala Gln Gln Ser Gly Thr Gly Glu Lys Gly Ala 45 50 55 ccg ttc atc gtc aat ggc gtc gag atg gct aac att cga ctt gtg ggg 303 Pro Phe Ile Val Asn Gly Val Glu Met Ala Asn Ile Arg Leu Val Gly 60 65 70 atg gtc aat gcc aag gtg gag cgg acg acc gat gtg acc ttc acg ctc 351 Met Val Asn Ala Lys Val Glu Arg Thr Thr Asp Val Thr Phe Thr Leu 75 80 85 gac gat ggc acc ggc cgc ctc gat ttc atc aga tgg gtg aat gat gct 399 Asp Asp Gly Thr Gly Arg Leu Asp Phe Ile Arg Trp Val Asn Asp Ala 90 95 100 105 tca gat tct ttt gaa act gct gct att cag aat ggt atg tac att gcg 447 Ser Asp Ser Phe Glu Thr Ala Ala Ile Gln Asn Gly Met Tyr Ile Ala 110 115 120 gtc att gga agc ctc aag gga ctg caa gag agg aag cgt gct act gct 495 Val Ile Gly Ser Leu Lys Gly Leu Gln Glu Arg Lys Arg Ala Thr Ala 125 130 135 ttc tca atc agg cct ata acc gat ttc aat gag gtt acg ctg cat ttc 543 Phe Ser Ile Arg Pro Ile Thr Asp Phe Asn Glu Val Thr Leu His Phe 140 145 150 att cag tgt gtt cgg atg cat ata gag aac act gaa tta aag gct ggc 591 Ile Gln Cys Val Arg Met His Ile Glu Asn Thr Glu Leu Lys Ala Gly 155 160 165 agt cct gca cga atc aat tct tct atg gga gtg tca ttc tca aat gga 639 Ser Pro Ala Arg Ile Asn Ser Ser Met Gly Val Ser Phe Ser Asn Gly 170 175 180 185 ttc agt gaa tca agc aca ccg aca tct ttg aaa tcc agt ccc gca ccg 687 Phe Ser Glu Ser Ser Thr Pro Thr Ser Leu Lys Ser Ser Pro Ala Pro 190 195 200 gtg acc agc ggg tca tcc gat act gat ctg cac acg cag gtc ctg aat 735 Val Thr Ser Gly Ser Ser Asp Thr Asp Leu His Thr Gln Val Leu Asn 205 210 215 ttt ttt aat gaa cca gcg aac ctc gag agt gag cat ggg gtg cac gtt 783 Phe Phe Asn Glu Pro Ala Asn Leu Glu Ser Glu His Gly Val His Val 220 225 230 gat gaa gta ctc aag cgg ttc aaa ctt ttg ccg aag aag cag atc acg 831 Asp Glu Val Leu Lys Arg Phe Lys Leu Leu Pro Lys Lys Gln Ile Thr 235 240 245 gat gct att gat tac aat atg gac tcg ggg cgt ctt tac tca aca att 879 Asp Ala Ile Asp Tyr Asn Met Asp Ser Gly Arg Leu Tyr Ser Thr Ile 250 255 260 265 gat gaa ttc cac tac aag gca act taaccgattt gaaggtcagc ctgctggaaa 933 Asp Glu Phe His Tyr Lys Ala Thr 270 tggcagagga ctaagtatca cttgtactaa accaaagtct ggaaatgtca tgttgtgtca 993 tgaaatgcat ggttggttta tggaaacatt tatatcttgt atcaactagt tgatttgtat 1053 ctcttgtgtc aacttaatga ctgagccaac aaaaggaaga tgtagaggca gacagacatt 1113 tgtagattgg ctgatagctg attcgggtag ctggtccaat tgcaatctgg ggcccaataa 1173 ttcagatgca aaagcagaaa gatatttcaa aaaaaaaaaa aaaaaaaaaa aaaaaaaa 1231 22 273 PRT Zea mays 22 Met Met Pro Leu Ser Gln Thr Asp Phe Ser Pro Ser Gln Phe Thr Ser 1 5 10 15 Ser Gln Asn Ala Ala Ala Asp Ser Thr Thr Pro Ser Lys Met Arg Gly 20 25 30 Ala Ser Ser Thr Met Pro Leu Thr Val Lys Gln Val Val Asp Ala Gln 35 40 45 Gln Ser Gly Thr Gly Glu Lys Gly Ala Pro Phe Ile Val Asn Gly Val 50 55 60 Glu Met Ala Asn Ile Arg Leu Val Gly Met Val Asn Ala Lys Val Glu 65 70 75 80 Arg Thr Thr Asp Val Thr Phe Thr Leu Asp Asp Gly Thr Gly Arg Leu 85 90 95 Asp Phe Ile Arg Trp Val Asn Asp Ala Ser Asp Ser Phe Glu Thr Ala 100 105 110 Ala Ile Gln Asn Gly Met Tyr Ile Ala Val Ile Gly Ser Leu Lys Gly 115 120 125 Leu Gln Glu Arg Lys Arg Ala Thr Ala Phe Ser Ile Arg Pro Ile Thr 130 135 140 Asp Phe Asn Glu Val Thr Leu His Phe Ile Gln Cys Val Arg Met His 145 150 155 160 Ile Glu Asn Thr Glu Leu Lys Ala Gly Ser Pro Ala Arg Ile Asn Ser 165 170 175 Ser Met Gly Val Ser Phe Ser Asn Gly Phe Ser Glu Ser Ser Thr Pro 180 185 190 Thr Ser Leu Lys Ser Ser Pro Ala Pro Val Thr Ser Gly Ser Ser Asp 195 200 205 Thr Asp Leu His Thr Gln Val Leu Asn Phe Phe Asn Glu Pro Ala Asn 210 215 220 Leu Glu Ser Glu His Gly Val His Val Asp Glu Val Leu Lys Arg Phe 225 230 235 240 Lys Leu Leu Pro Lys Lys Gln Ile Thr Asp Ala Ile Asp Tyr Asn Met 245 250 255 Asp Ser Gly Arg Leu Tyr Ser Thr Ile Asp Glu Phe His Tyr Lys Ala 260 265 270 Thr

Claims

What is claimed is:

1. An isolated protein comprising a polypeptide having at least 80% sequence identity over the full-length of SEQ ID NOS: 2 or 4, wherein the percent sequence identity is determined by the GAP algorithm under default parameters and wherein the polypeptide enhances homologous recombination as part of an RPA complex.

2. The polypeptide of claim 1, wherein the polypeptide has at least 85% sequence identity over the full-length of SEQ ID NOS: 2 or 4.

3. The polypeptide of claim 1, wherein the polypeptide has at least 90% sequence identity over the full-length of SEQ ID NOS: 2 or 4.

4. The polypeptide of claim 1, wherein the polypeptide has at least 95% sequence identity over the full-length of SEQ ID NOS: 2 or 4.

5. The polypeptide of claim 1, wherein the polypeptide is SEQ ID NOS: 2 or 4.

6. An isolated protein comprising a polypeptide encoded by SEQ ID NOS: 1 or 3, wherein the polypeptide enhances homologous recombination as part of an RPA complex.

7. An expression cassette comprising a polynucleotide operably linked to a promoter, wherein the polynucleotide encodes the polypeptide of claim 1.

8 A host cell comprising the expression cassette of claim 7.

9. A host cell comprising the polypeptide of claim 1.

10. The host cell of claim 9, wherein the host cell is a plant cell.

11. The plant cell of claim 10, wherein the plant cell is from a monocot.

12. The plant cell of claim 11, wherein the monocot is maize, sorghum, rice, barley, millet, rye, or wheat.

13. The plant cell of claim 10, wherein the plant cell is from a dicot.

14. The plant cell of claim 13, wherein the dicot is soybean, canola, alfalfa, sunflower, or safflower.

15. A plant comprising the host cell of claim 10.

16. The plant of claim 15, wherein the plant is a monocot.

17. The plant of claim 16, wherein the monocot is maize, sorghum, rice, barley, millet, rye, or wheat.

18. The plant of claim 15, wherein the plant is a dicot.

19. The plant of claim 18, wherein the dicot is soybean, canola, alfalfa, sunflower, or safflower.

20. A seed comprising the host cell of claim 10.

21. The seed of claim 20, wherein the seed is from a monocot.

22. The seed of claim 21, wherein the monocot is maize, sorghum, rice, barley, millet, rye, or wheat.

23. The seed of claim 20, wherein the seed is from a dicot.

24. The seed of claim 23, wherein the dicot is soybean, canola, alfalfa, sunflower, or safflower.

25. An antibody that selectively binds to an isolated polypeptide comprising an amino acid sequence selected from the group consisting of SEQ ID NO: 2 or 4.

26. An antibody that selectively binds to an isolated polypeptide comprising at least 20 contiguous amino acids of the amino acid sequence selected from the group consisting of SEQ ID NO: 2 or 4.

27. An isolated polypeptide wherein:

(a) the polypeptide comprises at least 20 contiguous amino acids of a polypeptide selected from the group consisting of SEQ ID NO: 2 or 4;

(b) the polypeptide, when presented as an immunogen, elicits the production of an antibody which specifically binds the polypeptide selected from the group consisting of SEQ ID NO: 2 or 4;

(c) the polypeptide does not bind to antisera raised against the polypeptide of SEQ ID NO: 2 or 4 after the antisera has been fully immunosorbed with the polypeptide of SEQ ID NO: 2 or 4; and

(d) the polypeptide enhances homologous recombination as part of an RPA complex.